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Perhaps no disease has been treated with more perfect empiricism on 
the one hand, or more rigid rationalism on the other than has epilepsy.  
         John Russell Reynolds, 1861 
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SUMMARY  
Corpus callosotomy is a palliative disconnective neurosurgical treatment that is 
typically employed for patients with medically refractory epilepsy characterised by 
injurious drop attacks. This thesis describes the 20 year experience with corpus 
callosotomy at Great Ormond Street Hospital for Children (GOSH) in London and 
the Children’s Hospital at Westmead (CHW) in Sydney.  
 
Between January 1995 and December 2015, 76 patients underwent corpus 
callosotomy at GOSH (n=47) and CHW (n=29); 55 patients met inclusion criteria. 
Patient records were analysed for changes in seizure type and frequency, changes 
in injuries, changes in use of antiepileptic drugs, and neurological and surgical 
complications. Rare or no drop attacks was analysed using Kaplan–Meier event-
free survival curves using right-censoring of data. Multivariable regression 
analysis was used to assess the effect of clinical characteristics on outcome at last 
follow up. 
 
Median follow up was 36 months (interquartile range 34 months). Overall 26/55 
patients (47.3%) had rare or no drop attacks at last follow up. Of the children who 
had drop attacks at last follow up, 26/29 of these patients (89.7%) had a return of 
drop attacks within 12 months of surgery. There were no significant predictors of 
developing drop attacks post-surgery. Neurological complications occurred in 
11/55 operations (20.0%) and resolved within 6 weeks in all patients. Surgical 
complications occurred in 6/55 operations (10.9%), with only one major 
complication (hydrocephalus) and no deaths. 
 
Corpus callosotomy was a well-tolerated palliative procedure that was effective at 
reducing the severity of drop attacks in this case series. In patients for whom drop 
attacks return, they are likely to do so within 12 months of surgery. Several other 
case series and systematic reviews provide evidence to support the hypothesis 
that corpus callosotomy is a safe and effective palliative treatment for patients 
with medically refractory generalised seizures that is typically characterised by 
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injurious drop attacks. But there is no strong evidence to demonstrate the validity 
of that hypothesis.  
 
A case study is presented to highlight some of the bioethical issues of corpus 
callosotomy in children. Parental resistance to epilepsy surgery is a well-known 
barrier to access for all epilepsy surgery. While earlier intervention has 
demonstrable benefits on quality of life, some parents find the prospect of 
disconnection syndrome challenging and resist corpus callosotomy. The case study 
is then used to frame issues relating to consent and the best interests of children 
undergoing corpus callosotomy, highlighting the shortcomings of the concept of 
autonomy.  
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1 INTRODUCTION 
Epilepsy is a heterogenous disease that poses a challenge for clinicians to treat. It is 
estimated that approximately 50 million people globally have epilepsy1,2. Typically 
70% of patients will undergo successful seizure remission with the use of medical 
treatment alone, 20% of patients will require lifelong treatment to control 
seizures, and the remaining 10% of patients will continue to have uncontrolled 
seizures despite medical treatment3,4. Such refractory epilepsy is especially 
disabling, often progressive, and carries a significant burden to patients and their 
families. Treatment of refractory epilepsy requires a comprehensive and 
multidisciplinary approach that may involve curative or palliative epilepsy surgery 
depending on the nature of the seizures. 
 
Corpus callosotomy is a palliative disconnective neurosurgical treatment for 
patients with either generalised or multifocal refractory epilepsy characterised by 
injurious drop attacks. Corpus callosotomy involves the surgical division of the 
corpus callosum (see Figure 1.1). It usually involves either a total division or a 
partial anterior division, in which the splenium is spared. Posterior corpus 
callosotomy on the other hand involves the division of the splenium only, but is 
rarely performed unless it is used to complete an anterior corpus callosotomy. 
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Figure 1.1. Corpus callosotomy. The schematic shows how the procedure is 
performed and the post-operative radiology images show the effect of the 
callosotomy in vivo. 
 
This chapter describes epilepsy, including the epidemiology, pathophysiology and 
the prognosis of epilepsy. The chapter then outlines the treatment of epilepsy 
before focusing on corpus callosotomy and its outcomes in paediatric patients. The 
chapter concludes with a brief discussion of difficult decision-making in epilepsy 
surgery to be explored in further detail in chapter 4. The systematic review by 
Graham, Tisdall and Gill on the outcomes of corpus callosotomy in paediatric 
patients5 established the theoretical groundwork for this thesis.  
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1.1 Epilepsy 
1.1.1 Definition 
An epileptic seizure is defined as “a transient occurrence of signs and/or 
symptoms due to abnormal excessive or synchronous neuronal activity in the 
brain”6. This is distinguished from non-epileptic seizures, which may mimic 
epileptic seizures but will have no electrical disruption and instead may have 
psychogenic or physiological causes. Epilepsy is a condition characterised by 
recurrent, unprovoked epileptic seizures. An epilepsy syndrome is a group of 
clinical characteristics that often co-occur, such as the seizure types, EEG findings, 
natural history, etc.  
1.1.2 Semiology 
The classification of seizures has evolved over many years, with early attempts 
dating back to Hippocrates and Galen, which highlights the difficulty of classifying 
the epilepsies7. The concepts of idiopathic and symptomatic date back to 1854 
when Delasiauve classified epilepsy into idiopathic (with no clear anatomical 
lesion), symptomatic (with a clear anatomical lesion) and sympathetic (arising 
secondary to other disease) 7. In 1931, Jackson suggested the classification take 
into account the presence of anatomical lesions, physiological disturbances and 
pathology, thereby introducing generalised and partial seizures7. This was an 
important step towards the current classification, but in 1955, Symonds observed 
that it may be difficult to clinically distinguish between generalised and partial 
seizures. In order to resolve this difficulty, he recommended the use of EEG, which 
is now the gold standard of diagnosis7.  
 
The International League Against Epilepsy (ILAE) first standardised the 
terminology in 1969, and has continued to update the classification as new 
technologies allow for improved diagnosis8. The current classification hierarchy is 
shown in Table 1.1 below, which is essentially a structured approach to describing 
the seizure. The approach is to determine whether the onset of the seizure is focal, 
generalised, unknown or unclassified. Further descriptors are then applied, 
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including level of awareness and secondary generalisation of a focal seizure to a 
bilateral tonic-clonic seizure. 
 
Table 1.1: Classification of epileptic seizures9. 
Level in 
Seizure 
Hierarchy 
Seizure Type Description 
1. Focal Seizure 
Further descriptors: aware, impaired 
awareness, unknown awareness; to 
bilateral tonic-clonic 
 1.1  Motor 
Focal motor seizures involve motor 
activity of parts of the body 
  1.1.1   Tonic 
Focal tonic seizures involve a strong and 
rigid contraction of the muscles that fixes 
the limbs in a strained position that lasts 
for seconds to minutes. A focal tonic 
seizure will involve parts of the body, 
such as a fencer’s posture seizure in 
which one arm will extend while the 
other flexes similar to the neonatal 
asymmetrical tonic neck reflex 
  1.1.2   Atonic 
Focal atonic seizures involve the loss of 
muscle tone. They are very brief and last 
for less than 2 seconds. 
  1.1.3   Myoclonic 
A myoclonic seizure is a sudden, brief 
(<100 ms) involuntary single or multiple 
contraction(s) of muscles(s) or muscle 
groups of variable topography (axial, 
proximal limb, distal) 
Chapter 1: Introduction 
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Level in 
Seizure 
Hierarchy 
Seizure Type Description 
  1.1.4   Clonic 
Clonic focal seizures involve convulsions 
in one part of the body. The amplitude of 
the convulsions remains constant 
throughout the seizure, but the frequency 
reduces. 
  1.1.5   Epileptic Spasms 
An epileptic spasm is a sudden flexion or 
extension (or mix) of one part of the body 
that lasts longer than a myoclonic jerk but 
shorter than a tonic seizure. 
  1.1.6   Hypermotor 
A hypermotor seizure consists of complex 
movements that involve proximal 
muscles and the trunk. They may be 
confused with night terrors in young 
children. 
 1.2  Non-Motor 
Focal non-motor seizures are focal 
seizures that do not involve motor 
activity 
  1.2.1   Sensory 
A focal sensory seizure is a perceptual 
experience that is not caused by an 
external stimulus. It may include 
auditory, gustatory, olfactory, 
somatosensory, vestibular or visual 
semiologies 
  1.2.2   Cognitive 
A focal cognitive seizure is a disturbance 
of cognitive function, and may include 
aphasia, dysphasia, déjà vu, jamais vu, 
hallucinations, memory impairment, 
neglect, etc 
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Level in 
Seizure 
Hierarchy 
Seizure Type Description 
  1.2.3   Emotional 
A focal emotional seizure is a disturbance 
of emotional or affective function, and 
may include agitation, fear, anxiety, 
crying, laughing, paranoia, pleasure, etc 
  1.2.4   Autonomic 
A focal autonomic seizure is a disturbance 
of autonomic function. It may manifest in 
any autonomic system, including 
cardiovascular (such as asystole), 
gastrointestinal (such as nausea and 
vomiting), thermoregulation, sexual, etc 
2. Generalised Seizure  
 2.1  Motor  
  2.1.1   Tonic-Clonic 
Tonic-clonic seizures have two phases. 
The tonic phase involves patient falling 
unconscious, possibly falling to the 
ground, and extension or flexion of 
extremities and may be preceded by aura. 
The clonic phase usually consists of 
violent muscle contractions, shaking or 
vibrating. The eyes may roll back in the 
head, the tongue may be bitten and 
incontinence may occur. Post-ictal 
phenomena may include sleepiness, 
headaches, amnesia and/or confusion. 
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Level in 
Seizure 
Hierarchy 
Seizure Type Description 
  2.1.2   Tonic 
Tonic seizures involve a strong and rigid 
contraction of the muscles that fixes the 
limbs in a strained position that lasts for 
seconds to minutes. The patient’s head 
and eyes may deviate to one side and they 
may turn around. As the seizure 
progresses, the intensity in different parts 
of the body changes. 
  2.1.3   Atonic 
Atonic seizures may involve either a head 
nod or complete loss of axial body tone. 
They are very brief and last for less than 
2 seconds. 
  2.1.4   Myoclonic 
Myoclonic seizures involve brief and 
shock-like jerks of a muscle or a group of 
muscles; awareness is usually preserved. 
  2.1.5   Myoclonic-atonic 
Myoclonic-atonic seizures involve a 
myoclonic seizure followed by an atonic 
seizure and typically results in a rapid 
fall. 
  2.1.6   Clonic 
Clonic generalised seizures involve 
generalised convulsions that lack the 
tonic phase seen in tonic-clonic seizures. 
The amplitude of the convulsions remains 
constant throughout the seizure, but the 
frequency reduces. They usually have a 
short postictal phase unlike tonic-clonic 
seizures. 
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Level in 
Seizure 
Hierarchy 
Seizure Type Description 
  2.1.7   Clonic-tonic-clonic 
Clonic-tonic-clonic seizures are a 
variation of tonic-clonic seizures that 
begin with a clonic phase. 
  2.1.8   Epileptic spasms 
An epileptic spasm is a sudden flexion or 
extension (or mix) of the trunk and 
proximal muscles that lasts longer than a 
myoclonic jerk but shorter than a tonic 
seizure. 
 2.2  Absence 
Absence seizures are subclassified as 
typical, atypical, myoclonic or eyelid 
myoclonia. 
  2.2.1   Typical Absence 
Typical absence seizures involve sudden 
onset interruption of activities with a 
blank stare, and can be brought on by 
hyperventilation or photic stimulation. 
The eyes may briefly rotate upwards and 
the patient will be unresponsive when 
spoken to. The seizure usually resolves 
rapidly after several seconds to half a 
minute with rapid recovery. 
  2.2.2   Atypical Absence 
Unlike in a typical absence seizure, the 
patient will be responsive and may be 
associated with other features such as 
loss of muscle tone or subtle myoclonic 
jerks.  
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Level in 
Seizure 
Hierarchy 
Seizure Type Description 
  2.2.3   Myoclonic Absence 
In addition to interruption of 
consciousness in a typical absence 
seizure, myoclonic absence seizures 
involve myoclonic jerks, which are 
typically bilateral. Automatisms may 
occur in which the patient may smack 
their lips, fumble with their clothes, or 
wander aimlessly. 
  2.2.4   Eyelid Myoclonia 
Again, in addition to what is seen in a 
typical absence seizure, the patient will 
exhibit flickering of the eyes. 
3. Unknown Onset 
This category allows for the initial 
classification of a seizure when the origin 
is not known. Further descriptors are the 
same as focal seizures: aware, impaired 
awareness, unknown awareness; to 
bilateral tonic-clonic.  
 3.1  Motor As per 1.1 and 2.1 
  3.1.1   Tonic-clonic As per 2.1.1 
  3.1.2   Tonic As per 2.1.2 
  3.1.3   Atonic As per 2.1.3 
  3.1.4   Epileptic spasms As per 2.1.8 
 3.2  Non-Motor As per 1.2 and 2.2 
4. Unclassified 
This category includes all types of 
seizures that can’t be classified according 
to the above schema due to inadequate 
information or unusual clinical features 
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Astatic seizures, also known as drop attacks, can be caused by either atonic, tonic, 
myoclonic or myoclonic atonic seizures. Drop attacks are a particularly debilitating 
form of seizure as they can cause serious injuries. Lennox-Gastaut Syndrome (LGS) 
is the archetypical syndrome refractory to medical treatment that is associated 
with drop attacks. LGS accounts for over 35% of paediatric patients who have been 
treated with corpus callosotomy5. Other diagnostic factors associated with LGS 
include cognitive or behavioural impairment and diffuse slow spike-wave activity 
on electroencephaplogram (EEG) with paroxysmal fast activity. LGS is an epileptic 
encephalopathy and patients will exhibit normal development until the onset of 
seizures, after which they will developmentally stagnate or regress. Bureau, 
Genton, Dravet et al provide a comprehensive description of LGS and other 
epilepsy syndromes10.  
 
1.1.3 Incidence and Prevalence 
Methodological inadequacies make the epidemiology of epilepsy difficult to assess. 
It is estimated that approximately 5-10 people per 1000 have epilepsy3. 
Generalised epilepsies and syndromes tend to be more prevalent in children 0 to 5 
years of age, while focal seizures tend to be more prevalent in older children11. The 
incidence of epilepsy is approximately 50 per 100 000 in industrialised countries, 
and 100-190 per 100 000 in resource poor countries3. The incidence of epilepsy is 
strongly age dependent, with the highest incidence in the first year of life12. There 
is some evidence that the incidence is decreasing in children, which may be due to 
a number of factors such as improved perinatal care, increased immunisation, and 
improved maternal health. Estimates of the risk of developing epilepsy after a first 
unprovoked seizure vary from 40-50%13, but can be much higher if the aetiology is 
known14.  
 
Evidence is emerging that there may be social determinants of epilepsy. In their 
data linkage study, Pickerell et al found that the prevalence and incidence of 
epilepsy in Wales is strongly related to deprivation15. Two possible explanations 
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could be proposed: 1) epilepsy negatively impacts the socioeconomic status of the 
family (social drift theory); or 2) socioeconomic status is a risk factor for the 
development of epilepsy (social cause theory). The cross-sectional design of the 
Pickerell et al study does not allow for a causal link to be found, but there was no 
significant change in socioeconomic status a decade after the diagnosis was made. 
This led the authors to conclude that social determination is a better explanation 
than social drift15.  
 
There was a similar finding for disabled children in the Longitudinal Study of 
Australian Children (LSAC)16 and the Longitudinal Study for England and Wales17. 
Both studies used logistic regression models to show that family disadvantage in 
early childhood is associated with the development of a disability later in 
childhood17,16. While these were cohort studies that were designed to find causal 
linkages for disability, it is not unreasonable to infer deprivation as risk factor for a 
disability like epilepsy. It is worth considering that the universal healthcare model 
afforded by Medicare in Australia and the NHS in the UK ought to provide at least 
some prevention of epilepsy if social deprivation is a key risk factor. It may be the 
case that a universal healthcare model limits the amount of social drift, and a wider 
social solution is needed to support primary prevention. This raises questions 
about access to healthcare for children with epilepsy, which will be discussed later 
in the context of disability. 
 
1.1.4 Aetiology 
Until recently, the aetiology of epilepsy was classified as idiopathic, cryptogenic 
and symptomatic. Our understanding of the underlying aetiology of epilepsy has 
considerably expanded in recent years thanks to advances in modern 
neuroimaging and genetic testing. Epilepsies are now described more precisely by 
their specific underlying aetiologies, namely: genetic, structural, metabolic, 
immune, infectious and unknown. 
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CNS infections are the most common cause of epilepsy worldwide and as such 
infectious aetiologies of epilepsy have important public health consequences, 
particularly in developing countries. Infectious causes may be bacterial, viral, 
protozoal, parasitic and, more rarely, prion disease. Bacterial causes can include 
meningococcus, pneumococcus, haemophilus influenza b and tuberculosis, and 
may result in meningitis or encephalitis. Viral causes may include human 
immunodeficiency virus, herpes simplex virus 1, and other less common causes of 
viral encephalitis. Congenital cytomegalovirus is an important foetal cause of 
epilepsy and can result in malformations of cortical development. Cerebral malaria 
is the most common protozoal aetiology, while toxoplasmosis and 
neurocysticercosis are common parasitic causes. Creutzfeld-Jacob disease may 
present with new onset seizures. The specific cause will impact the treatment 
choice. 
 
Immune aetiologies of epilepsy involve the sterile inflammation of the CNS and can 
involve both innate and adaptive immune systems. While antibody mediated 
causes are strongly supported by biochemical data such as specific neuroreceptor 
antibodies, other types of immune-mediated epilepsy are less clear or may be 
based on clinical response to the use of anti-inflammatory drugs in some infantile 
epilepsies. Moreover, innate immunity is hypothesised to contribute to seizures 
and epileptogenesis. This complex and active area of research is outside the scope 
of this thesis, but Granata et al provide an excellent overview of immune-mediated 
epilepsy18. 
 
Structural and metabolic conditions or diseases can be associated with a 
substantially increased risk of developing epilepsy. Structural lesions include 
acquired disorders such as stroke, trauma, and infection, but may be of genetic 
origin (eg. tuberous sclerosis and many malformations of cortical development). 
Metabolic epilepsies may be due to mitochondrial disorders, disorders of 
transportation of key nutrients (such as folate, glucose), disorders of synthesis of 
biochemicals, and disorders of metabolism and recycling of biochemicals (eg. 
biotin). While the metabolic epilepsies and some structural epilepsies are caused 
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by a genetic defect, there is a separate process interposed between the genetic 
defect and the epilepsy.  
 
Genetic causes of epilepsy are therefore difficult to disentangle from other causes 
of epilepsy. As noted above, most metabolic disease has a genetic cause, but the 
genetic defect in a metabolic epilepsy is not the direct cause of the seizure. Rather 
the metabolic disease results in nutritional deficits or the build-up of waste 
products, which in turn cause seizures. Genetic epilepsy on the other hand involves 
a genetic defect in which seizures are the core symptom of the disorder, and the 
defect is not mediated from the seizure by another disease process. The knowledge 
regarding the genetic contributions may derive from specific molecular genetic 
studies that have been well replicated and even become the basis of diagnostic 
tests (e.g., SCN1A for Dravet syndrome) or the evidence for a central role of a 
genetic component of the disease may come from appropriately designed family 
studies. Designation of an epilepsy as genetic does not exclude the possibility that 
environmental factors (outside the individual) may contribute to the expression of 
disease.  
 
1.1.5 Pathophysiology 
The pathophysiology of epilepsy is not fully understood but involves neuronal 
hyperexcitability and neuronal hypersynchronicity at the cellular level that leads 
to a paroxysm of discharges in the cortex or brainstem19, which may be due to 
changes in glutamatergic and GABA-ergic systems, and also catecholamine and 
opioid systems. Genetic and structural abnormalities may contribute to this 
hyperexcitability and hypersynchronicity. Generalised epileptic seizures rapidly 
engage bilaterally distributed networks that may be either cortical or subcortical20. 
However, the location and lateralisation of generalised seizures may not always be 
consistent and seizures may be asymmetric. Focal epileptic seizures on the other 
hand originate within networks that are limited to one hemisphere that may be 
focal or widely distributed20.  
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Advances in neuroimaging and bioinformatics are providing insights into the 
interactions between neurons and behaviours emerging from their connectivity. 
This has opened up the new field of connectomics, which is the study of maps of 
connections within a nervous system called connectomes. Connectomics can be 
studied from a structural or functional perspective, or at the local circuit level. 
Engel et al have recently speculated that epilepsy research could benefit from 
studying the connectomics of epilepsy21.  
 
There are complex connectomics associated with generalised seizures. Fast EEG 
rhythms and spikes can be induced by the thalamus, whereas slow rhythms are 
induced by inhibitory thalamic systems. Bursts of fast rhythms are 
characteristically cortical. Oscillations may originate in the thalamus, the cortex or 
involve a dysfunction of thalamo-cortical loops. Such oscillations can be 
synchronised by the thalamus and by the corpus callosum. This complex interplay 
of multiple potential sources of seizure activity and EEG abnormalities suggests 
that generalised seizures may involve the entire brain22. 
 
While the history of generalised seizures has long benefited from studies into the 
nature of neuronal circuitry, challenges do remain. More recently, complex 
systems theory has been used to espouse the concept of system epilepsies as a 
hypothesis for certain types of generalised seizures23. In this theory, ictogenesis 
arises as an emergent property of the entire network and does not depend on a 
focal lesion. Avanzini et al propose absence epilepsy and juvenile myoclonic 
epilepsy as two examples of system epilepsies24, Capovilla et al propose epileptic 
encephalopathies (notably LGS and West Syndrome) as another set of examples25.   
 
1.1.6 Diagnosis 
A diagnosis of epilepsy depends largely on clinical evaluation (see Table 1.2). EEG 
however is the gold standard investigation to confirm whether the seizure is 
indeed epileptic, which can be conducted with video telemetry so that signs can be 
correlated with EEG rhythms. 
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Table 1.2. Key diagnostic factors for epilepsy 
History 
Onset 
The onset is important. Is it rapid? Is there a 
prodrome? Are there precipitating factors? 
Description 
Careful history of the seizure, including 
eyewitness accounts, is important to first 
determine whether the event is a seizure and 
second to characterise the seizure as generalised 
or focal and its semiology. 
Duration 
Variable depending on the semiology (see table 
1.1) 
Resolution 
Ictal and post-ictal factors include incontinence, 
tongue biting on the lateral margins during a 
tonic-clonic seizure, presence of any post-ictal 
phenomena such as somnolence and confusion 
Precipitating 
Factors 
Precipitating factors include lack of sleep, 
hyperventilation, or light/noise. 
Associated 
Conditions 
Common associated conditions include attention-
deficit hyperactivity disorder (ADHD), autism 
spectrum disorder (ASD), developmental delay, 
learning disability and psychiatric conditions  
Past Medical 
History 
Strong risk factors include: perinatal asphyxia, 
metabolic/neurodegenerative disorders, head 
trauma, structural abnormalities of the CNS, 
some neurocutaneous syndromes (Sturge-Weber 
syndrome, tuberous sclerosis).  
Weak factors include: ASD, CNS infection, some 
neurocutaneous syndromes (neurofibromatosis 
type 1), history of febrile seizures. 
Family and Family history of epilepsy is a strong risk factor. 
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Social History 
Examination 
General Neurocutaneous stigmata may be present. 
Neurological 
Generally a neurological examination does not 
provide much information unless the patient is 
examined during a seizure. 
Developmental 
Developmental delay is common among epilepsy 
syndromes, either preceding the onset of 
epilepsy or as the consequence of epileptic 
encephalopathy. 
Investigations 
EEG 
Epileptic discharges may be seen on inter-ictal 
recording. Abnormal rhythms are characteristic 
for type of syndrome, such as diffuse slow spike 
and waves while awake and fast rhythmic and 
slow polyspikes while asleep in LGS. However, 
diagnosis may require the provocation of 
seizures by titrating antiepileptic drugs (AED) 
down, using photic stimulation or sleep 
deprivation, etc.  
MRI 
Magnetic resonance imaging (MRI) is useful 
when the diagnosis is in doubt or a secondary 
cause is suspected. MRI is becoming increasingly 
of clinical value, especially with refractory 
epilepsy and is important for planning resective 
surgery of refractory focal epilepsy.  
CT 
Computer tomography (CT) is useful for 
excluding intra-cerebral bleeding or a space 
occupying lesion. CT may be used if MRI is not 
available, though CT is generally inferior to MRI 
in the investigation of epilepsy.  
Genetic 
Genetic panels and CGH arrays are increasingly 
valuable in the work up of epilepsy as they can 
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provide important prognostic information and 
guide treatment 
Auto-
Antibodies 
Autoimmune screens are an important 
investigation in the appropriate setting as 
autoimmune causes may be treated with 
intravenous immunoglobulin (IVIG) and 
corticosteroids 
Other 
Other investigations are used to exclude non-
epileptic causes: 
1. Blood glucose to exclude hypoglycaemic 
cause.  
2. Basal metabolic panel to exclude 
metabolic disorders or electrolyte 
imbalances.  
3. FBC and cultures to exclude infection.  
4. Lumbar puncture (LP) to exclude 
infection and inflammation. 
5. Electrocardiogram (ECG) to exclude 
cardiac causes, especially long QT 
syndrome. 
 
There is a wide range of differentials for epilepsy. Broadly these can be classed as: 
syncope, anoxic seizures, behavioural/psychological/psychiatric disorders, sleep 
related conditions, paroxysmal movement disorders, migraine disorders, and 
miscellaneous. The two most common differentials are syncope and psychogenic 
nonepileptic events26. Table 1.3 below shows how these differentials can be 
differentiated from epilepsy on history and eyewitness accounts. 
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Table 1.3. Distinguishing between seizures and syncope and psychogenic 
nonepileptic events26. 
Characteristic Seizure Syncope Psychogenic 
Aura 
Variable (see 
semiology) 
None Uncommon 
Onset Acute Acute Acute or gradual 
Duration 
Variable (see 
semiology) 
Seconds to 
minutes 
Several minutes to 
hours 
Movements 
Variable (see 
semiology) 
Loss of tone, 
myoclonus 
Eye closure; 
asynchronous, 
pelvic thrusting; 
atypical features 
Trauma due to the 
episode 
Occasional Occasional Rarely 
Pre-ictal posture No impact Erect or standing No impact 
Can occur 
immediately upon 
waking 
Yes No No 
Post-ictal phase Confusion 
Rapid return to 
baseline 
Rapid return to 
baseline 
 
1.1.7 Comorbidities 
Population based studies have found that approximately 75% of children with 
epilepsy have a disability4. Worsening seizures can occur with particular 
anticonvulsants, but usually occurs when an inappropriate anticonvulsant is 
initiated when the underlying cause is unknown or wrong. Developmental delay 
and intellectual disability are often associated with the underlying aetiology of 
epilepsy. The underlying mechanism of epilepsy can result in epileptic 
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encephalopathies, leading to a regression in development. These associated 
conditions may be exacerbated by drug toxicity and status epilepticus. 
 
The prevalence of psychopathology is difficult to assess due to the heterogeneity of 
epilepsy and differing diagnostic techniques27. While estimates for the entire 
population are wide as 20-80%27, roughly 50-60% of children with epilepsy have a 
psychopathology, in particular mood disorders and psychosis28. Multiple factors 
are associated with this risk, including age, underlying aetiology of epilepsy, 
medication effects, encephalopathy, the type of syndrome and its severity, among 
others. Psychiatric symptoms can occur peri-ictally and interictally; interictal 
symptoms may be regarded as comorbid27. 
 
Hyperhomocysteinaemia and hyperlipidaemia can occur as the result of certain 
anticonvulsants (carbamazepine, phenobarbital, phenytoin, valproic acid) and the 
presence of homozygous 5-methylenetetrahydrofolate reductase polymorphism. 
These conditions are associated with the development of long-term sequelae such 
as cardiovascular disease, which has raised concerns about the chronic use of 
carbamazepine, phenobarbital, phenytoin, valproic acid in children29. Cross-
sectional studies have found patients with epilepsy have an increased prevalence 
of cardiovascular risk factors compared with the general population30. Renoux et 
al’s population-based cohort study in the United Kingdom found no association 
between AED and ischaemic stroke31. However there was a small increase in the 
risk of myocardial infarction with P450 inducing drugs, but valproic acid was 
associated with a decreased risk31. 
 
1.1.8 Prognosis 
Seizure freedom is synonymous with a good prognosis, though epilepsy with onset 
in infancy and early childhood often runs a more severe course. There is a good 
prognosis in 70-80% of children with idiopathic epilepsy and late onset of 
seizures, and in those without associated neurological dysfunction32. The 
remaining 20-30% of patients will continue to have epilepsy despite treatment3,33.  
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Rapid response to therapy is an important predictor of lasting remission, along 
with age of onset, number of seizures early in the condition, response to AED, EEG 
characteristics such as slow spike and wave patterns, and may include normal MRI 
and IQ>503,14,34. But the most important prognostic factor is likely to be the 
aetiology of seizures14.  
 
Seizure onset in infancy is more likely to be associated with comorbidities and 
worse outcomes, although there are some self-limiting epilepsy syndromes of 
infancy. Evolution to other epilepsy syndromes may occur regardless of age or type 
of epilepsy. For example, West syndrome may evolve to LGS, myoclonic epilepsy of 
infancy may evolve to infrequent generalised tonic clonic seizures (GTCS), and 
childhood absence epilepsy may evolve to either juvenile absence epilepsy or 
juvenile myoclonic epilepsy.  
 
Treatment with AED after the first seizure reduces the risk of seizure recurrence, 
but there is no evidence of a difference when treatment is started after the first 
versus second seizure in achieving 2-year seizure remission35,36. Indeed, there is 
some epidemiological evidence to support the proposition that a significant 
number of patients will achieve seizure freedom with or without treatment with 
AED3.  
 
Early intervention with resective surgery reduces the progress of epileptic 
encephalopathy and both resective and disconnective surgery have been 
associated with improved lifespan37. There is a well-documented “burden of 
normality” following successful epilepsy surgery, which must be managed 
carefully38. Features of the “burden of normality” include38:  
1. Psychological: Changes in the concept of self are at the core of the burden of 
normality as the patient transitions to a “well self,” and is especially 
challenging in adolescents. Patients may feel the need to demonstrate their 
normality as they try to make up for lost time and may feel a sense of 
increased expectations to succeed. Conversely, patients may feel a sense of 
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grief over the loss of a disease that formed a core part of their identity, and 
may feel a sense of lost opportunities and a need to make up for lost time. 
2. Behavioural: Patients may exhibit changes in activities including non-
adherence to pharmacological management. Patients may take on too much 
as they try to demonstrate their normality, or the converse could be true if 
they resist new expectations. 
3. Affective: Patients may experience changes in mood, from the euphoria of a 
cure, to anxiety of increased expectations, to depression, frustration and 
regret. 
4. Sociological: Family dynamics may shift as the roles of patients and carers 
change, as well as changes in attitudes of family and friends towards the 
patient. New vocational and social opportunities open up, including 
freedoms associated with driving and the shift from the sick role. 
 
 
Mortality rates are substantially higher among patients with epilepsy than the 
general population, even with good seizure control3. The potential causes of death 
include injury, infection (eg. aspiration pneumonia), suicide, status epilepticus and 
sudden unexpected death in epilepsy (SUDEP). Immediate treatment with AED 
does not reduce the risk of death in patients with a first unprovoked seizure, but 
the risk of death is higher in those who have refractory epilepsy39.  
 
1.1.9 Prevention 
There is currently no primary or secondary prevention for epilepsy. Patients and 
their families should be comprehensively informed about possible precipitating 
factors that could exacerbate seizures, such as avoiding photostimulation and sleep 
deprivation in patients with juvenile myoclonic epilepsy. Patients who experience 
drop attacks can experience injuries, and so appropriate headwear may be 
necessary. However, precipitating factors are highly variable and will depend on 
the individual patient, so a comprehensive history is essential.  
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1.2 Treatment 
Antiepileptic drugs (AED) are the mainstay of epilepsy treatment. Surgery is either 
palliative or curative in intent and is reserved for refractory epilepsy only, in which 
patients fail 2 or more well-chosen drugs with ongoing epilepsy. Other options 
include non-drug therapies such as a ketogenic diet and lifestyle measures (i.e., 
avoiding any precipitating stimuli such as sleep deprivation and alcohol 
consumption). Occupational therapy may be important if the seizures are severe 
enough to cause injury. For example helmets may be required in order to prevent 
craniofacial injuries resulting from drop attacks.  
 
This section will focus on pharmacological and surgical treatment but 
acknowledges the importance and efficacy of ketogenic diets and lifestyle 
modifications. Cannabinoids are an active (and controversial) area of research for 
the treatment of refractory generalised seizures40, but they will not be discussed 
here due to the limited clinical data. 
 
1.2.1 Pharmacological Treatment 
Pharmacological interventions are generally the first line treatment. The 
overarching principle by AED action is to reduce neuronal excitation. This is 
currently achieved via 7 mechanisms41: 
1. Target excitatory synapses: 
a. Enhance sodium channel inactivation, thereby reducing neuronal 
firing frequency 
b. Inhibit excitatory amino acid release by blocking calcium channels 
c. Inhibit excitatory amino acid release by blocking synaptic vesicle 
glycoproteins (notably SV2A (synaptic vesicle glycoprotein 2A)) 
d. Antagonise AMPA receptors (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid) and kainite receptors 
e. Antagonise NMDA (n-methyl-d-aspartic acid) receptors 
2. Target inhibitory synapses: 
a. Enhance GABA (γ-aminobutyric acid) action 
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b. Inhibit GABA breakdown 
c. Inhibit GABA uptake 
 
Two new drugs have increased selectivity of receptors involved in the action of 
excitatory synapses. Levetiracetam targets the synaptic vesicle glycoprotein SV2A, 
thereby reducing the release of excitatory amino acids. Perampanel selectively 
antagonises AMPA receptors. The action of GABA analogues such as pregabalin and 
gabapentin however is unknown. While they do increase levels of GABA in the 
cerebrospinal fluid (CSF), they bind to L-type calcium channels thereby inhibiting 
excitatory amino acid release. Figure 1.2 below illustrates the mechanisms used by 
various AEDs.  
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(a)
(b) 
Figure 1.2. Mechanism of action of AEDs; a) drugs targeting excitatory synapses; b) 
drugs targeting inhibitory synapses41. 
 
In practice, the choice of AED depends on the seizure semiology and epilepsy 
syndrome, the use of other medications and the presence of any comorbidities, 
pregnancy plans and patient preferences. In principle, only one drug should be 
used at a time with one treating physician in charge. Doses should be titrated 
slowly until seizures are controlled or side-effects become intolerable, or the 
maximum dosage has been achieved. Some AED algorithms for different seizure 
semiologies are shown in Table 1.4 below and represent a general consensus, but 
practice is centre- and syndrome-specific. For instance, lamotrigine, 
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carbamazepine and phenobarbital act on SCN1A and thereby worsen Dravet 
syndrome42.  
 
Table 1.4. AED algorithms for different seizure semiologies. 
Semiology First Line Second Line Others 
GTCS 
Sodium valproate 
or lamotrigine 
Carbamazepine or 
topiramate 
Levetiracetam, 
oxcarbazepine, 
clobazam 
Absence 
Sodium valproate, 
lamotrigine or 
ethosuximide 
  
Myoclonic, tonic, 
atonic 
Sodium valproate 
or lamotrigine 
Topiramate 
Levetiracetam, 
clobazam 
Partial seizures Carbamazepine 
Sodium valproate, 
lamotrigine, 
oxcarbazepine or 
topiramate 
Levetiractam, 
gabapentin, 
tiagabine, 
phenytoin, 
clobazam 
 
1.2.2 Surgical Treatment 
Surgical treatment is only considered for refractory epilepsy, which occurs in 
approximately 10% of cases, and only then when the risks associated with 
refractory epilepsy (eg injury, developmental delay, etc) outweigh the harms of 
surgery. Even still, epilepsy surgery is more often indicated in focal seizures rather 
than generalised seizures. 
 
The surgical intent differs according to whether the seizures are focal or 
generalised. A curative intent with resective surgery is typically used in the 
treatment of focal seizures. A palliative intent is typically used in generalised 
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surgery. Options for generalised seizures include VNS and corpus callosotomy. As 
the focus of this thesis, corpus callosotomy will be discussed in detail below. VNS is 
an important alternative treatment to corpus callosotomy. VNS involves the 
insertion of an electrical stimulator beneath subcutaneous tissue, which is 
connected to the vagus nerve at the carotid sheath. The relative efficacy compared 
with corpus callosotomy will be discussed in section 1.3.2 below. 
 
A number of classification systems exist for the seizure outcomes of epilepsy 
surgery, with some authors choosing their own classification system. The most 
widely used system is the Engel classification43. The ILAE classification is also used 
and is consistent with the Engel classification44. The Engel classification is shown 
in Table 1.5 below since it will be used to base the definition of a good outcome in 
this thesis. 
 
Table 1.5. The Engel classification system 
Engel class Definition 
Class I Free from disabling seizures 
          IA Completely seizure free 
          IB Nondisabling simple partial seizures only 
          IC 
Some disabling seizures after surgery, but free from disabling 
seizures for ≥2 years 
Class II Rare disabling seizures (almost seizure free) 
          IIA Initially free from disabling seizures but still has rare seizures 
          IIB Rare disabling seizures 
          IIC Occasional disabling seizures, but rare seizures for the last 2 years 
          IID Nocturnal seizures only 
Class III Worthwhile improvement 
          IIIA Worthwhile seizure reduction 
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          IIIB 
Prolonged seizure free intervals amounting to >50% of follow up but 
not <2 years 
Class IV No worthwhile improvement 
          IVA Significant seizure reduction 
          IVB No appreciable change 
          IVC Worsening of seizures 
 
The choice of classification of seizure outcomes may affect the significance of 
outcomes. Stringent definitions of good outcome tend to detect significantly better 
seizure outcomes for total corpus callosotomy than anterior corpus callosotomy. 
Such systems include the Engel classification system, which has recently been 
shown to have good inter-rater reliability, but there was only 1 disconnective 
surgery in the series of 76 patients44. A consistent and stringent classification 
system is important for assessing the effectiveness of corpus callosotomy and is 
important for reviewing the literature. The assessment of seizure outcomes is 
further complicated by the fact that patients usually have additional often severe 
neuropsychological problems. So it is worth noting that other outcomes may be 
more important to parents in the paediatric setting than seizure reduction and 
have received little attention in the literature5. These will be discussed in detail 
below. 
 
1.3 Corpus Callosotomy 
1.3.1 Rationale  
The pathophysiological basis of the use of corpus callosotomy is the hypothesis 
that the corpus callosum is the most important pathway for the spread of epileptic 
activity between the two hemispheres of the brain34. Figure 1.3 shows the anatomy 
of the corpus callosum is divided rostro-caudally into five parts: the rostrum, the 
genu, the body, the isthmus and the splenium. The genu and rostrum together 
account for approximately 1/3 of the entire corpus callosum, the body accounts for 
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approximately 1/3 of the entire corpus calosum, and the splenium and the isthmus 
account for approximately 1/3 of the entire corpus callosum45. The splenium 
accounts for approximately 1/5 of the entire corpus callosum, and is an important 
landmark for corpus callosotomy. 
 
The corpus callosum is not the only interhemispheric connection in the human 
brain: the anterior, middle, habenular and posterior commissures as well as 
thalamic and brainstem structures provide alternate interhemispheric white 
matter connections.  
 
 
Figure 1.3. Anatomy of the corpus callosum (plate 715)46. 
 
This hypothesis was first proposed after Van Wagenen and Herren published a 
case series on 10 patients with tumours of the corpus callosum47. As the tumors 
progressed, generalised seizure activity reduced and became confined to a single 
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hemisphere. The hypothesis was later tested in monkey-models48 and the 
technique was employed in the first commisurotomy in humans47.  
 
However the postoperative morbidity of a commisurotomy can be very high49, 
most notably disconnection syndrome, which was studied by Sperry in patients 
who had undergone commisurotomy and compared them to patients with agenesis 
of the corpus callosum50. Disconnection syndrome presents with a combination of 
alien limb, apraxia, tactile and/or visual anomia, agraphia, neglect, dyslexia. 
Patients may have difficulty naming or recognising objects when they cross the 
midline, they may experience alien limb syndrome, find reading and writing 
difficult, and find speech difficult. This poses a challenge to the rehabilitation of 
patients. 
 
Based on this work, corpus callosotomy was proposed by Sperry’s student 
Gazzaniga as an approach to reduce the likelihood of disconnection syndrome. 
Corpus callosotomy was subsequently demonstrated to be sufficient for reducing 
generalised seizures and resulted in lower postoperative morbidity than 
commisurotomy49. Spencer, Spencer, Williamson et al were the first to report on 
the anterior division of the corpus callosum51, which involves the sparing of the 
splenium with the aim to reduce the possibility of disconnection syndrome. They 
argued that the corpus callosotomy should only be completed if there has been an 
incomplete response to the anterior corpus callosotomy52. Others have also 
reported on posterior division of the corpus callosum. While Pinard et al found a 
poor response to treatment in 3 patients53, one recent case series of 36 patients 
demonstrated a good response to treatment with posterior corpus callosotomy 
and suggest that there are more favourable connectomics54. 
 
1.3.2 Paediatric Outcomes 
In the first systematic review of the paediatric literature, Graham, Tisdall and Gill5 
found 12 papers that reported corpus callosotomy outcomes in patients under the 
age of 18 at the time of surgery, and with at least 1 year median follow up53,55-65. 
Corpus Callosotomy Outcomes in Paediatric Patients 
30  David Graham - March 2018 
They found that 88.2% of patients who underwent complete corpus callosotomy 
were either free or almost free of drop attacks compared with 58.6% of patients 
who underwent anterior corpus callosotomy. Drop attacks showed greater 
benefits of corpus callosotomy compared with other generalised seizures. In 
studies that used outcomes based on the Engel classification system, significantly 
more complete corpus callosotomy patients had a worthwhile reduction in drop 
attacks compared with partial corpus callosotomy patients5. This is reflected in the 
broader literature on corpus callosotomy34,66.  
 
VNS is reported to be no better than corpus callosotomy5,67, although Cukiert et al 
found that corpus callosotomy was superior to VNS for drop attacks55. 
Nevertheless VNS is a reversible intervention with fewer complications. Cukiert et 
al have proposed that VNS could be offered as an initial treatment option before 
progressing to corpus callosotomy due to its reversible nature55, but Rathore et al 
have observed that VNS is more expensive than corpus callosotomy, so can be 
prohibitive in developing countries59. 
 
Corpus callosotomy has not been associated with a reduction in the number of 
AED5. Three papers in Graham et al’s review reported formal neuropsychiatric 
outcomes60,64,65. 83% of patients had significantly improved behaviour following 
surgery5,59,63-65 and 82% of patients had improved psychomotor function5,53. 
Nevertheless, there was no significant change in IQ or DQ following surgery5,60,64. 
However if a modest reduction in seizure can be achieved, parents may rate the 
outcome highly5,59. Indeed, most parents report they are pleased with the 
outcomes and would recommend corpus callosotomy to others58,59,61,64.  
 
Adverse outcomes after corpus callosotomy include neurological complications 
and surgical complications. Neurological complications include the onset of new 
seizures, disconnection syndrome and other neurological conditions. Surgical 
complications include hydrocephalus, infections, CSF leaks, deep vein 
thrombosis/pulmonary embolus (DVT/PE), pneumonia, haematomas and 
metabolic disturbences5. Up to 20% of patients will develop new onset seizures, 
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but they are more likely to be generalised seizures than partial seizures5. The 
development of new onset seizures is equally likely regardless of extent of the 
callosotomy. Disconnection syndrome occurred in 7% of all patients reviewed by 
Graham, Tisdall and Gill and was significantly more likely in complete corpus 
callosotomy compared with partial corpus callosotomy (13% vs 0%; p<0.05) 5. 
Remarkably, disconnection syndrome was always transient and usually only 
occurred in children with either LGS or severe intellectual disability. Other 
neurological complications were also transient and occurred in 13% of patients 
and are equally likely regardless of extent of callosotomy5. Surgical complications 
occurred in up to 6% of patients and are equally likely regardless of extent of 
callosotomy and the reported mortality rate was 0.26%5.  
 
Outcomes in paediatric patients are better than those reported in adult patients5. 
Paediatric patients are more likely to have a reduction in seizures following 
surgery and less likely to develop complications. However, there is no reported 
correlation with age or earlier surgery in this population5, despite the fact that 
earlier surgery is generally preferred in epilepsy surgery68. 
 
Diffusion tensor imaging (DTI) studies have been used to investigate the 
microstructural changes following corpus callosotomy69-71. These studies show 
that the early reductions in white matter tracts are consistent with axonal 
degradation, while later reductions are consistent with myelin degradation71. Such 
degenerations persist in the long term, though some intact fibres may remain 
following surgery70. However DTI is limited to the evaluation of white matter 
integrity. Diffusion tensor fibre tracking (DT-FT) on the other hand allows the 
integrity of the white matter tracts to be evaluated, which can provide an overview 
of the impact of the corpus callosotomy on white matter tracts and thereby 
potentially support a more informed prognosis69. From a treatment perspective, 
DTI combined with functional MRI (fMRI) could enable the epileptogenic brain 
structures to be better defined and thereby support more effective surgical 
treatment21. 
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Overall the quality of the evidence on outcomes from corpus callosotomy is low 
due to the fact that the included studies each had an inherent risk of bias in their 
design5. The level of evidence for corpus callosotomy is appropriate for raising 
hypotheses regarding corpus callosotomy as a treatment for refractory generalised 
seizure. However authors consistently concluded that corpus callosotomy is a safe 
and effective treatment. Such conclusions can only be confirmed with case control 
or randomised trials. Dwivedi et al recently conducted an RCT of 116 patients 
undergoing epilepsy surgery in India72. They used a similar randomisation to 
Wiebe et al’s landmark epilepsy surgery RCT73 and included 10 patients who 
underwent corpus callosotomy and compared them with 16 patients waiting for 
corpus callosotomy. However none of the corpus callosotomy patients achieved 
seizure freedom compared with only one of the control group. Seizure freedom is 
an uncommon outcome in this group of patients and may be a reflection of the 
need for a trial specifically designed to assess corpus callosotomy outcomes. 
Appendix A expands on the broad scope of an RCT for corpus callosotomy as 
outlined by Graham, Tisdall and Gill5. 
 
1.4 Difficult Decision-Making 
The evidence suggests that corpus callosotomy is likely to be a highly effective and 
safe procedure5. While there is a risk of neurological complications, notably 
disconnection syndrome, these complications usually resolve in children and 
earlier intervention has demonstrable benefits on quality of life37. However, some 
parents find the prospect of disconnection syndrome challenging and resist corpus 
callosotomy despite the good body of evidence. This raises a number of ethical 
questions that are not sufficiently addressed by the evidence, such as access, 
consent, and best interests. Chapter 4 uses a clinical case study to frame some of 
these bioethical issues of corpus callosotomy. 
 
There are multiple stakeholders involved in epilepsy surgery – the patient and 
their parents, the treating team, the hospital administration, federal and state 
health departments, and society. Each stakeholder has different and at times 
conflicting objectives, which is highlighted by the case in chapter 4. Moreover, the 
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stakeholders often have limited knowledge about the incentives considered by 
other stakeholders as well as their decisions. But this highly complex interplay of 
stakeholders rests on the surrogate consent of the parents. 
 
The second opinion can be an invaluable technique to help parental decision-
making. A second opinion offers a means to increase certainty for parents and 
patients as to the considerations of the treating team, as well as the likely position 
of the hospital and health departments. Alternative therapies to corpus 
callosotomy, such as VNS, may also be discussed, and opportunities to meet 
parents of former patients may also be beneficial. Ultimately this underlines the 
value of patient education in this complex decision-making process.  
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2 STUDY METHODS 
While 88% of paediatric patients reported to achieve no or rare drop attacks 
following complete corpus callosotomy5, this figure is based on the outcome at last 
follow up. Indeed, in their review of epilepsy surgery, Telléz-Zenteno et. al. found 
sustained freedom from drop attacks diminishes significantly beyond 5 years74. 
More recently, Stigsdotter-Broman et al’s population study of long term outcomes 
found that sustained benefit is possible up to 10 years75. Given that it is not clear 
how the efficacy of corpus callosotomy changes over time, it is reasonable to 
investigate how the effect of corpus callosotomy on the primary seizure (drop 
attacks) evolves. Yet this approach has not been published in the corpus 
callosotomy literature.  
 
This chapter details the methods that will be used in Chapter 3. The original data 
from this thesis has been published in the international peer review journal 
Developmental Medicine & Child Neurology76, which is reproduced in Appendix B. 
 
2.1 Ethics 
Ethics approval for this study was granted by the Sydney Children’s Hospital 
Network Human Research Ethics Committee (HREC Reference 
LNR/14/SCHN/178) and the GOSH Clinical Audit Department (Registration 
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Number 1974). The applications were to review the clinical data on all patients 
who had undergone corpus callosotomy at GOSH and CHW. 
 
2.2 Aim and Objectives 
The aim of this thesis is to: 
1. Describe the outcomes of 20 years of experience with corpus callosotomy at 
GOSH and CHW.  
 
In line with this aim, the objectives of this thesis are to: 
1. Describe the tolerability of corpus callosotomy. This objective will be 
achieved by analysing the surgical and neurological complications directly 
attributable to the corpus callosotomy at GOSH and CHW. 
2. Describe the efficacy of corpus callosotomy. This objective will be achieved 
through the analysis of the effect on the primary seizure type (namely drop 
attacks), the impact on injuries from drop attacks, the effect on other 
seizure types, and any changes in AED usage. The effect on drop attacks will 
be analysed for durability of outcome using a Kaplan-Meier survival 
analysis. 
3. Identify any clinical predictors of good drop attack outcomes. This objective 
will be achieved through the use of multivariable regression analysis of a 
number of clinical factors that have been found to be predictors of good 
outcomes of drop attacks based on the study by Asadi-Pooya et al34. 
 
It should be noted that this thesis is a retrospective study and therefore can only 
be used for hypothesis generation rather than testing. Nevertheless, as an 
observational study I hope that this data will be valuable for assessing the safety of 
corpus callosotomy. 
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2.3 Search Strategy 
Data for this study was sourced from an exhaustive search of all clinical records for 
each patient who underwent corpus callosotomy at GOSH and CHW during the 
period January 1995 to December 2015. The search was done in order to 
accurately record patient demographics, the clinical progression of seizure 
semiology, any complications of surgery or epilepsy, and changes in AED regime. 
Database searches were conducted on location at each hospital in order to 
maintain data security.  
 
The databases differed slightly between sites and therefore the search strategies 
used at each location was different:  
1. GOSH: Complete medical records for epilepsy surgery patients at GOSH are 
maintained at the departmental level. Microsoft Project was used to 
conduct searches for all patients who had undergone corpus callosotomy at 
GOSH by entering corpus callosotomy as a keyword. The Microsoft Project 
search results linked directly to all records stored in the GOSH database for 
each patient. 
2. CHW: Medical records for patients at CHW are maintained at the hospital 
level. A patient list based on medical records numbers was available at the 
CHW department of neurology and neurosurgery. Patients were identified 
from these records and then cross-checked with the Department of Medical 
Records, who were able to conduct a complete search of Power Chart for all 
patients who had undergone corpus callosotomy. The Power Chart search 
results linked directly to all patient electronic records stored in the hospital 
database, however there were six patients who still had data on Microfilm. 
These records were reviewed in the Department of Medical Records. By 
doing this cross checking, it was possible to ensure that all eligible patients 
were captured who were eligible by complementing multiple search 
methods. 
 
These database searches returned a significant amount of clinic letters and notes, 
correspondences, emergency admissions, imaging studies, neurophysiological 
Corpus Callosotomy Outcomes in Paediatric Patients 
38  David Graham - March 2018 
studies, neuropsychological assessments, nursing phone calls, and allied health 
assessments and notes. I retrieved the vast majority of data for this study from 
these records. I used an earlier and less detailed dataset obtained by Dr Kavitha 
Kothur in order to validate my own dataset. I also developed a simple proforma of 
outcome data designed for a phone interview and enlisted the help of the GOSH 
epilepsy service clinical nurse consultant Ms Nicola Barnes in order to attempt to 
contact 17 GOSH patients who were lost to follow-up. 
 
The process of encoding this data is detailed in Section 2.7.2 below.  
 
2.4 Definitions 
2.4.1 Seizures 
Seizure semiology is defined in Chapter 1 according to the 2016 ILAE Commission 
on Classification. Refractory epilepsy is defined as “the failure of adequate trials of 
two tolerated and appropriately chosen and used AED schedules (whether as 
monotherapies or in combination) to sustain seizure freedom”77. Table 1.4 
provides typical AED regimes, with first and second line AEDs for a number of 
different seizure semiologies.  
 
2.4.2 Corpus Callosotomy 
Corpus callosotomy is defined as the surgical division of the corpus callosum. The 
corpus callosotomy is classified according to the planned extent of callosal section: 
1. Partial corpus callosotomy: Any corpus callosotomy that plans to spare 
parts of the corpus callosum is defined as a partial corpus callosotomy: 
a. Anterior 2/3 corpus callosotomy: division of the corpus callosum 
while sparing the splenium and the isthmus. 
b. Anterior 3/4 corpus callosotomy: division of the corpus callosum 
and sparing the splenium and approximately half of the isthmus. 
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c. Anterior 4/5 corpus callosotomy: division of the corpus callosum 
and sparing only the splenium. 
d. Posterior corpus callosotomy: division of the splenium and the 
isthmus of the corpus callosum. 
2. Complete corpus callosotomy: Any corpus callosotomy that is planned to 
divide the entire corpus callosum are classified as having a complete corpus 
callosotomy: 
a. Complete corpus callosotomy: division of the entire corpus callosum 
until the Vein of Galen can be identified intraoperatively. 
b. Subtotal corpus callosotomy: division of the corpus callosum with 
rostral parts of the splenium remaining. The Vein of Galen was not 
identified intraoperatively but the surgeon has assessed the division 
to be sufficient to close the craniotomy. This may occur if the caudal 
extent of the division becomes offset.  
3. Completion of corpus callosotomy: Patients with prior anterior corpus 
callosotomy undergoing further surgery for a complete corpus callosotomy 
were classed as having a completed corpus callosotomy. This was the only 
circumstance under which a posterior corpus callosotomy was performed 
at GOSH or CHW. 
4. Abandoned: A procedure is defined as abandoned if the surgeon has 
performed a craniotomy but not proceeded with the division of the corpus 
callosum. One callosotomy was abandoned at GOSH due to tortuous 
anatomy of the bridging veins. 
 
2.4.3 Imaging 
Imaging findings were defined using the Barkovich classification system of 
malformations of cortical development78. The Barkovich classification system uses 
a developmental and genetic approach to classify malformations of the cortex. The 
classification hierarchy is shown in Table 2.1. 
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Table 2.1. The Barkovich classification system of malformations of cortical 
development. 
Group Description 
Group I 
Malformations secondary to abnormal 
neuronal and glial proliferation or 
apoptosis 
 Group I.A Severe congenital microcephalies 
 Group I.B Megalencephalies 
 Group I.C 
Cortical dysgenesis with abnormal cell 
proliferation but without neoplasia, 
such as tuberous sclerosis and focal 
cortical dysplasia type II 
 Group I.D 
Cortical dysgenesis with abnormal cell 
proliferation and with neoplasia 
Group II 
Malformations due to abnormal 
neuronal migration 
 Group II.A 
Heterotopias, including periventricular 
nodular heterotropia, periventricular 
heterotropia, and ribbon-like 
heterotopia 
 Group II.B 
Lissencephalies (with or without 
subcortical band heterotopia) 
 Group II.C 
Subcortical heterotopia and sublobar 
dysplasias 
 Group II.D Cobblestone malformations 
Group III 
Malformations secondary to abnormal 
postmigrational development 
 Group III.A Polymicrogyria and schizencephaly 
Chapter 2: Study Methods 
David Graham - March 2018   41 
Group Description 
 Group III.B 
Cortical dysgenesis secondary to inborn 
errors of metabolism 
 Group III.C 
Focal cortical dysplasias (FCD) without 
dysmorphic neurons, namely Type I and 
Typle III FCD 
 Group III.D 
Postmigrational developmental 
microcephaly, such as Rett syndrome, 
Angelman syndrome 
 
2.4.4 Neuropsychology 
Neuropsychological assessment assesses a patient’s cognitive ability in a number 
of areas including: memory, attention, processing speed, reasoning, judgment, 
problem-solving, spatial function, and language function79. Table 2.2 shows the two 
key assessment domains reported in epilepsy surgery patients80. 
 
Table 2.2. Neuropsychological assessment domains 
Domain Description 
Developmental delay 
Severity of developmental delay was 
defined as mild (IQ<70), moderate 
(IQ<50), severe (IQ<30) 
Behaviour 
Formal diagnosis of Attention-
Deficit/Hyperactivity Disorder (ADHD) 
and Autism Spectrum Disorder (ASD), 
as well as behavioural qualifiers such as 
cooperative, aggressive, agitated, 
somnolent, etc 
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2.4.5 Neurophysiology 
Ictal EEG and video EEG (VEEG) changes were defined using the classification 
system used by Hanson et al81. In their study of corpus callosotomy in adults, 
Hanson et al noted a difference in outcome based on the ictal type, but no 
relationship with interictal changes81: 
1. Type I: onset of generalised slow spike-wave, electrodermal patterns, or 
fast activity with low amplitude; 
2. Type II: build-up of generalised activity or asymmetrical onset of activity. 
 
2.4.6 Complications 
Severity of surgical and neurological complications were classified using a similar 
system defined by Hader et al82, as shown in Table 2.3 below. 
 
Table 2.3. Severity of complications. 
Complication Type Major Minor 
Surgical Hydrocephalus 
Deep infections (such as 
intracerebral and 
epidural 
abscesses) requiring 
drainage 
and/or bone flap removal 
CSF leak 
Intracranial/extracranial 
infection 
Aseptic meningitis 
DVT/PE 
Pneumonia 
Intracranial haematomas 
Metabolic disturbances 
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Complication Type Major Minor 
Neurological  All neurological 
complications that 
persisted 
beyond 3 months of 
surgery 
All transient neurological 
complications resolving 
within 3 months of 
surgery 
 
2.5 Corpus Callosotomy Procedure 
2.5.1 Patient Workup 
Patients with refractory epilepsy were referred for consideration of epilepsy 
surgery at each unit. This involved a detailed multidisciplinary review of the 
patient history and examination findings, seizure semiology, neuropsychological 
assessment, neurophysiological studies, and imaging. Patients were considered for 
corpus callosotomy if they had generalised refractory epilepsy with drop attacks. 
The decision for partial or complete corpus callosotomy was based on 
neuropsychological assessment; patients with poor cognitive function, especially 
verbal function, were more likely to be selected for complete corpus callosotomy. 
Completion of corpus callosotomy was based on post-operative seizure control. 
 
Patients were worked up for corpus callosotomy as described by Cross et al80: 
1. EEG: interictal scalp EEG including natural sleep recordings, as well as VEEG 
for recording ictal events. These were obtained using standard techniques 
described by the International Federation of Clinical Neurophysiology83. 
2. Structural Imaging: MRI using a specified epilepsy protocol; CT was utilised 
when indicated, such as calcification. Special sequences were required for 
infants and children under 24 months old due to their immature myelation; 
serial sequences were also used in this group in order to identify 
abnormalities. 
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3. Neuropsychology: age appropriate intelligence, development and 
behavioural tests. 
 
While the guidelines by Cross et al were published in 2006, and so only cover a 
decade of the present case series, it is important to note that these guidelines were 
developed at GOSH and it is therefore not surprising that the work up of GOSH 
patients has been consistent with Cross et al’s guidelines. Moreover, there is a 
strong historical collaboration between CHW and GOSH, and so CHW adopted a 
similar work up for their patients consistent with these guidelines. 
 
2.5.2 Surgical Approach 
The surgical approach and technique in both centres involved a single craniotomy 
over the midline and centred on the coronal suture. Depending upon the vascular 
anatomy, the callosotomy was performed to the left of the falx cerebri. This defines 
a plane for dissection.  
 
The dissection was taken to the planned posterior extent of the corpus 
callosotomy. Anterior corpus callosotomy included any callosal section that aimed 
to spare the splenium and all or part of the isthmus. Complete corpus callosotomy 
included any callosal section that aimed to divide the splenium to the Vein of 
Galen. The callosotomy then proceeded caudo-rostrally until the anterior cerebral 
arteries could be identified. The depth of the disconnection of the corpus callosum 
proceeded until the ependyma was identified. There are no anatomical landmarks 
so neuronavigation offered the best intraoperative decision tool. The loss of 
accuracy as the division advances was small due to the fact that the procedure was 
midline. 
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2.5.3 Follow Up 
This was a retrospective study that used all available routine medical, nursing and 
allied health correspondences and emergency department admissions, as well as 
any clinically necessary imaging and neurophysiological studies and 
neuropsychologial assessments.  
 
All patients were followed up within 6 weeks of surgery. Ongoing follow up was 
recorded where available in the medical records. Owing to the severity and 
complexity of refractory generalised seizures, most patients were followed up 
regularly with formal consultant review, plus nursing staff regularly contacted 
patients and their families. Follow up clinics involved a detailed review of the 
patient history and seizure semiology and frequency. AED efficacy and side effects 
were also reviewed for appropriateness and titrated if necessary. Parents were 
also asked about any concerns that they may have and were invited to ask 
questions.  
 
When a patient’s epilepsy was worsening, new seizure types were emerging, or the 
seizures were not improving despite treatment, further investigations were 
conducted. These included additional imaging or VEEG. Further 
neuropsychological assessments were also conducted if clinically indicated. 
 
2.6 Patient Selection 
All patients who underwent corpus callosotomy at CHW and GOSH between 
January 1995 and December 2015 were considered for inclusion. Patients were 
excluded from the study based on the following exclusion criteria:  
1. Age at Surgery: The patient was 18 years or older at the time of surgery and 
therefore not considered a paediatric patient even though they underwent 
surgery at CHW or GOSH. This typically occurred if the patient was well-
known to the paediatric epilepsy service, or if the patient had a significant 
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level of developmental delay and/or other comorbidities that made the 
patient too complex for treatment in an adult setting. 
2. Lost to Follow Up: The patient was considered lost to follow up if they had 
less than 3 months follow up. This occurred if the post-surgery clinic was 
the only clinical record available after surgery.  
3. Additional Resection: If the patient underwent additional resective surgery 
at the time of surgery, they were excluded as this could cloud the results of 
the corpus callosotomy outcomes.  
 
A total of 76 patients underwent corpus callosotomy at GOSH (n=49) and CHW 
(n=27) over this period. This included 5 patients who had a completion of their 
anterior corpus callosotomy and 1 complete corpus callosotomy patient for whom 
the surgery was abandoned. An intention to treat principle was used to analyse 
these patients: 
1. Completion of Corpus Callosotomy: The patients with previous anterior 
corpus callosotomy were analysed in that cohort until completion. These 
patients were then analysed as part of the complete corpus callosotomy 
cohort following completion of their corpus callosotomy.  
2. Abandoned Corpus Callosotomy: The patient for whom a complete corpus 
callosotomy was abandoned was analysed in the complete corpus 
callosotomy cohort. 
 
A total of 55 patients met final inclusion criteria (GOSH n=33; CHW n=22). The 
following exclusion criteria were met by 21 patients: 
1. Age at Surgery (n=2): Two patients were 18 years old at the time of 
surgery, one at GOSH and one at CHW. Both patients were severely 
developmentally delayed. They were treated at CHW and GOSH due to the 
higher levels of ward-based experience with patients with severe 
developmental delay. 
2. Lost to Follow Up (n=18): Records other than the post-surgical follow up 
for 3 CHW patients and 15 GOSH patients were not available:  
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a. CHW: The three CHW patients were private patients who underwent 
surgery at CHW due to the higher levels of ward-based experience 
with epilepsy surgery.  
b. GOSH: The GOSH epilepsy service registered nurse, Ms Nicola 
Barnes, attempted to contact 17 GOSH patients who had been lost to 
follow up. She was able to make contact with 2 patients who were 
included in the cohort. Four patients were referred to GOSH from 
other UK hospitals. They were discharged back to their local 
hospitals for follow up. The remaining 11 GOSH patients were 
international patients from the Middle East (n=8), continental 
Europe (n=2) and the Republic of Ireland (n=1). They were treated 
at GOSH under a diplomatic exchange and followed up in their home 
countries. However there was no extended follow up beyond three 
months.  
3. Additional Resection (n=1): One patient at CHW also underwent a temporal 
lobectomy at the time of surgery. This patient had generalised seizures 
secondary to a herpes simplex virus infection. 
 
2.7 Data 
2.7.1 Data Sources 
The following data sources were used: 
1. Patient history and seizure semiology described in outpatient clinics letters, 
which were the primary source of data and provided an overarching view of 
the patient’s post-surgical trajectory. Patients typically attended clinics 
every 6 months, and would attend a post-surgical clinic at 6 weeks 
following surgery. Seizure semiology was recorded from the clinic letters 
and coded using the ILAE 1989 classification of seizures described in Table 
1.18. These notes also included demographic data, seizure frequency, detail 
on AED regimes, injuries sustained from drop attacks, and any behavioural 
concerns raised by parents. 
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2. Pre-operative neuropsychological assessments detailed patient DQ or IQ, 
and their behaviour and cognition. These reports also provided a rich 
source of patient history to complement clinic letters. 
3. Imaging studies were included as part of the epilepsy surgery workup for 
each patient. They were used to identify structural aetiologies of epilepsy, 
and in 30 patients provided confirmation of the extent of corpus 
callosotomy. 
4. Ictal and interictal scalp (or intracranial grid) EEG/VEEG studies. These 
studies also included a rich source of patient history to complement clinic 
letters. 
5. Genetic studies were conducted in 21 patients. These provided another 
source of patient history to complement clinic letters as well as detailed 
data on genetic aetiologies of epilepsy. 
6. Emergency department and surgical discharge summaries also provided 
rich detail on complications of epilepsy, comorbidities, injuries following 
drop attacks, and complications of surgery. However data from emergency 
departments was not available for all patients as both GOSH and CHW are 
referral centres from other hospitals where patients would present with 
injuries. 
 
2.7.2 Data Collection 
Data was collected from the sources described above in five phases for each of the 
76 patients. Inclusion criteria were assessed on the basis of this data collection, 
with 21 patients being excluded from the study. The data collection phases for 
each patient are as follows: 
1. Pre-surgical data collection: The pre-surgical patient history was reviewed 
from clinical correspondences, with emphasis placed on the letters closest 
to admission for surgery. This allowed the following data to be collected: 
a. Patient demographics: date of birth, epilepsy diagnosis, epilepsy 
aetiology, comorbidities, age at seizure onset, age at surgery, 
planned type of surgery.  
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b. Seizure data: seizure semiology and seizure frequency as described 
in the correspondences, including any reports of injuries from drop 
attacks. Seizure frequency was classified as daily, weekly, monthly or 
occasional for each seizure type. Whenever they occurred, injuries 
were a cause for concern for parents and were reported within 
formal clinics. This was noted by the consultant and included in their 
correspondences. 
c. Investigation data: imaging studies, VEEG results and genetic 
studies. 
d. Assessment data: IQ/DQ test results, behavioural assessments and 
diagnoses.  
e. Treatment data: previous AED drugs and doses, presence of VNS and 
status, history of other epilepsy surgery, trials of ketogenic diet. 
f. Other: demographic data allowed for exclusion of patients older than 
18 at the time of surgery and other resective surgery at the time of 
corpus callosotomy.  
2. Last follow up data collection: The patient history at last follow up were 
reviewed from clinical correspondences. The following data was collected 
at this phase:  
a. Seizure data: seizure semiology and seizure frequency as described 
in the correspondences, including any reports of injuries from drop 
attacks. This is described above in phase 1. 
b. Investigation data: further imaging studies, further VEEG results and 
genetic studies. 
c. Assessment data: further IQ/DQ test results, further behavioural 
assessments. It should be noted however that formal assessment 
was only conducted for 11 patients. 
d. Treatment data: current AED drugs and doses, further surgery or 
VNS implantation, trials of ketogenic diet.  
e. Other: this was an important data collection phase as patients were 
excluded if the last follow up was at the post-surgical clinic, which 
occurred within the first 6 weeks. 
3. Post-surgical data collection: Post-surgical clinic letters were reviewed for 
seizure semiology, completeness of callosotomy, and complications. Where 
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possible the completeness of the callosotomy was reviewed on post-
surgical imaging reports. 
4. Return of drop attacks data collection: If patients continued to have drop 
attacks at last follow up, correspondences and letters were reviewed in 
order to identify the time post-surgery that drop attacks had returned. 
Seizure semiology and frequency as described in these correspondences, as 
well as reports of injuries sustained as the result of drop attacks, were 
recorded. 
5. Additional data collection: Any additional data that was not collected in any 
of the preceding 4 data gathering phases was searched for in imaging 
reports, neurophysiological studies, neuropsychological assessments, and 
genetic studies. 
 
2.7.3 Data Entry 
Data was entered into an excel spreadsheet using the data sources described in 
section 2.7.1. The data fields are shown in Table 2.4. 
 
Table 2.4. Data fields for capturing data from patient records 
Data Type Data Element Description 
Patient ID De-identified signifier 
Coded number unrelated 
to Name, Address or 
medical record number 
Demographics 
Sex Male or Female 
Syndrome 
LGS, West syndrome, 
Ohtahara syndrome, 
Doose syndrome, Sturge-
Weber syndrome, Dravet 
syndrome, myoclonic 
epilepsy of infancy, or any 
other epilepsy syndrome 
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Data Type Data Element Description 
Aetiology 
Genetic, structural, 
metabolic, infective, 
inflammatory, unknown 
Comorbidities 
ASD, ADHD, cerebral 
palsy (CP), etc 
Age at epilepsy onset 
Age in months at epilepsy 
onset as described in 
source data 
Age at surgery Age in months at surgery 
Age at last follow up 
Age in months at last 
follow up 
Age at return of drop 
attacks (if applicable) 
Age in months based on 
first discussion of drop 
attacks in source data 
following surgery 
Age at death (if 
applicable) 
Age in months 
Seizure Semiology 
Seizure semiology (pre-
surgery, post-surgery, last 
follow up, return of drop 
attacks) 
Number and types of 
seizures, frequency of 
seizures (daily, weekly, 
monthly, sporadic), 
regular injuries as a result 
of drop attacks 
Surgery 
Extent of callosotomy 
Anterior 2/3, Anterior 
4/5, Subtotal, Total, 
Abandoned, Completed 
Neurological 
complications 
Minor and major 
complications as defined 
in table 2.4 
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Data Type Data Element Description 
Surgical complications 
Minor and major 
complications as defined 
in table 2.4 
Investigations 
Imaging 
MRI findings classified 
using the Barkovich 
classification 
Ictal and inter-ictal EEG  
(pre-surgery, post-
surgery, last follow up) 
EEG findings classified 
using Hanson 
classification in table 2.3 
Genetic studies 
Karyotype, COL4A1, TSC2, 
MeCP2 duplication, etc 
Neuropsychological 
Assessment 
Developmental delay 
(pre-surgery, post-
surgery, last follow up) 
Severity level as defined 
in table 2.2 
Behaviour (pre-surgery, 
post-surgery, last follow 
up) 
Formal diagnosis as well 
as qualifiers as described 
in table 2.2 
Treatment 
Diet  (pre-surgery, post-
surgery, last follow up) 
Any special diets, namely 
ketogenic diet 
AED  (pre-surgery, post-
surgery, last follow up) 
Number of AED 
VNS  (pre-surgery, post-
surgery, last follow up) 
Presence and status of 
VNS (active or inactive) 
Corpus callosotomy 
Previous anterior corpus 
callosotomy, previously 
abandoned corpus 
callosotomy 
Other epilepsy surgery  Resection, callosotomy 
 
Chapter 2: Study Methods 
David Graham - March 2018   53 
2.8 Outcomes 
Seizure outcomes were based on the Engel classification, which is shown in table 
1.5. A good outcome was defined as completely seizure free or almost seizure free. 
This definition is consistent with Tellez-Zenteno et al’s systematic review of 
epilepsy surgery 74 and Graham et al’s systematic review of corpus callosotomy in 
paediatric patients5, and consequently allows for ready comparison with the 
literature. 
 
The primary outcome for this study was a good outcome for drop attacks. While 
there is some controversy over its use in disconnective surgery, the Engel 
classification system is clinically relevant and commonly used in clinical practice 
for reporting epilepsy surgery outcomes as well as the literature5. Therefore the 
Engel classification system has been used as the basis for the definition of good 
outcome in this thesis; the phrase “Engel Class I-II” has not been used in order to 
avoid confusion as this could imply “completely or almost seizure free.” Other 
classification schemes have been used in the literature and may be more 
appropriate, but the Engel classification allows for ready comparison with the 
majority of the literature. Therefore a good outcome was defined as free or almost 
free of drop attacks. 
 
Drop attacks were classified as tonic, atonic, or myoclonic8. Data on their frequency 
and outcome were collected from clinic reports as described above.  
 
The following secondary outcomes were also included: 
1. Other seizure outcomes at last follow up: based on Engel class I-II outcome, 
good outcome for other seizures was defined as free or almost free of 
generalised seizures, partial seizures and spasms at last follow up. New 
onset seizures were also analysed. 
2. Injury outcomes at last follow up: The number of patients who were 
reported to be sustaining injuries between clinic appointments as a result of 
their drop attacks at the time of surgery compared with those at last follow 
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up. This was noted in clinic notes for all patients as it was of significant 
concern to parents. 
3. Changes in the number of AED at last follow up: The number of AED at the 
time of surgery compared to the number of AED at last follow up. 
4. Surgical and neurological complications: The severity of surgical and 
neurological complications were classified using Table 2.4 above. Data 
obtained from post-surgical clinics and surgical reports was readily 
amenable to this classification system. 
5. Neuropsychological changes at last follow up: Formal neuropsychological 
assessments at last follow up were compared with formal 
neuropsychological assessments conducted as part of the patient workup. 
6. Neurophysiological changes at last follow up: Formal neurophysiological 
findings were classified according Hanson et al’s classification described 
above using a post hoc approach. The findings at last follow up were 
compared with the findings from patient workup. 
 
2.9 Statistical Analysis 
All statistical analysis were conducted using SAS version 9.4. All p-values were 
two-tailed and significance was defined as p < 0.05. 
 
Categorical data was compared using Fisher’s exact test and interval data was 
compared using Mann-Whitney’s U test. Fisher’s exact test is more accurate than 
Pearson Chi square test when the number of patients is small, such as in this 
present study. The test was used to compare data in a 2x2 matrix of patients in two 
groups, say GOSH and CHW patients, with a given category, say female or male. The 
Mann-Whitney U test was used in preference to Student’s t-test as it does not 
require the assumption of normality of data. The test was used to compare (for 
instance) age distribution at GOSH and CHW. The null hypotheses that were tested 
with each of these tests were that there was no significant difference between the 
two statistics being compared. 
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The time while patients continued to have a good outcome for drop attacks was 
analysed using Kaplan–Meier event-free survival curves using right-censoring of 
data and the logrank test; right-censor date was 31 December 2015. Kaplan-Meier 
event-free survival is used to estimate the proportion of patients who remain free 
of events, in this case drop attacks. In this study, patients were censored when they 
had a shorter follow up compared to the remainder of the cohort. This means that 
the total survival time of those patients is not known, and so they cannot be 
included in the analysis beyond the time they have been censored. The logrank test 
is a non-parametric test that allows survival curves to be compared and is 
appropriate to be used when right-censoring of data.  
 
Initial seizure free period of 12, 18 and 24 months post-surgery was also analysed 
using a landmark analysis. A landmark analysis separates the cohort into two 
groups:  
1. Those who are either censored up to a chosen point in time or who fail 
before that point in time; and  
2. Those who are censored beyond the chosen point in time or who fail after 
that point in time.  
 
The landmark analysis “re-sets” the clock at the landmark time, say 12 months. For 
instance, if 20/50 patients are censored or do not survive the initial 12 months of a 
Kaplan-Meier curve, the curve for the remaining 30 patients can be compared to 
the curve for all 50 patients using logrank statistics. 
 
The following clinical features have been associated with good seizure outcome in 
the literature34 and were modelled using the logrank test for statistical significance 
as well as multivariable logistic regression analysis:  
1. Age at onset; 
2. Age at surgery;  
3. Tonic drop attacks;  
4. Extent of callosotomy (anterior vs complete);  
5. Diagnosis of LGS, West Syndrome or Ohtahara Syndrome;  
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6. Moderate-severe developmental delay; and  
7. Abnormal MRI features.  
 
Backward selection was used for the multivariable logistic regression model; Wald 
Chi square statistic was used to test for significance and Harrell’s C statistic was 
used for goodness of fit. 
2.10 Data Storage 
Data was collated, de-identified and then stored on hospital encrypted password 
protected drives at CHW and GOSH. Data was only combined after de-identification 
and transferred via hospital email. Data will be stored for 5 years and destroyed 
using data shredding software in accordance with the approved ethics. 
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3 OUTCOMES OF CORPUS 
CALLOSOTOMY 
In the absence of any definitive evidence, there are currently no universally 
accepted indications for corpus callosotomy, and patient selection is centre and 
surgeon dependent. Therefore individual case series can highlight new discoveries 
about the efficacy and safety of the procedure.  
 
A total of 55 patients met the inclusion criteria, which makes this one of the largest 
case series of corpus callosotomy in the paediatric population5,61,63 (Graham 2016, 
Shimizu 2005, Shimizu & Maehara 2001). However, it is not clear whether there is 
overlap between the other two large case series by Shimizu (2005)61 and Shimizu 
& Maehara (2001)63, and moreover those two case series had methodological 
flaws5. 
 
The results and analysis in this chapter has been published by the international 
peer-reviewed journal Developmental Medicine and Child Neurology using the 
methods described in Chapter 276. 
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3.1 Patient Demographics 
Pre-surgery demographic data is shown in Table 3.1, with p values for the 
comparison of CHW with GOSH. The median age at surgery was significantly older 
at CHW (147.5 months vs 111 months, p=0.021). All patients at both centres had 
drop attacks at the time of surgery, but there were significantly more patients with 
myoclonic-atonic drop attacks at CHW (6 vs 0, p=0.002). There were significantly 
more atonic seizures (3 vs 0, p=0.049) and myoclonic seizures (12 vs 6, 
p=0.0075) at CHW. A total of 11/55 patients underwent anterior corpus 
callosotomy, 43/55 patients underwent complete corpus callosotomy. 
 
Table 3.1. Pre-surgery demographics. 
Demographic GOSH CHW All p 
Number of patients (n) 33 22 55 - 
M:F (n:n) 25:8 11:11 36:19 0.075 
Extent of callosotomy (n) 
 Anterior 8/33 3/22 11/55 0.29 
 Complete 24/33 19/22 43/55 0.24 
 Completed 3/8 2/3 5/11 1.0 
 Abandoned complete 1/33 0/22 1/55 1.0 
 Abandoned anterior 0/33 0/22 0/55 1.0 
Lennox Gastaut Syndrome, 
West Syndrome or Ohtahara 
Syndrome (n) 
21/33 12/22 33/55 0.57 
 Lennox Gastaut 
Syndrome (n) 
15/33 12/22 27/55 0.59 
 West Syndrome (n) 4/33 0/22 4/55 0.14 
 Ohtahara Syndrome (n) 2/33 0/22 2/55 0.51 
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Demographic GOSH CHW All p 
Known aetiology (n)  20/33 11/22 31/55 0.57 
 Structural 9/33 6/22 15/55 1.0 
 Genetic 6/33 2/22 8/55 0.45 
 Metabolic 0/33 1/22 1/55 0.40 
 Immune 0/33 1/22 1/55 0.40 
 Infectious 2/33 1/22 3/55 1.0 
Moderate-Severe 
Developmental Delay (n) 
28/33 21/22 49/55 1.0 
Other comorbidities excluding 
developmental delay (n) 
19/33 10/22 29/55 0.41 
Median Age (Interquartile Range; IQR) (months) 
 Epilepsy onset 10 (31) 24 (25) 12.5 (30) 0.81 
 Surgery 
111 (90) 
147.5 
(52.25) 
125 
(81.5) 
0.021 
Investigations (n) 
 Abnormal MRI 18/33 12/22 30/55 0.19 
 Chromosome 
abnormality 
1/2 0/2 1/4 1.0 
 Microdeletion/ 
duplication 
4/11 3/6 7/17 1.0 
Seizure semiology at the time of surgery 
Drop Attacks (n) 
 Any 33/33 22/22 55/55 1.0 
 Tonic 9/33 7/22 16/55 1.0 
 Atonic 16/33 5/22 21/55 0.15 
 Myoclonic 1/33 3/22 4/55 0.63 
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Demographic GOSH CHW All p 
 Myoclonic-atonic 0/33 6/22 6/55 0.002 
 Not stated 6/33 1/22 7/55 0.23 
Other generalised seizures (n) 
 Any 28/33 21/22 49/55 0.39 
 Tonic-Clonic 13/33 9/22 22/55 1.0 
 Absence 17/33 8/22 25/55 0.57 
 Tonic 12/33 10/22 22/55 0.57 
 Atonic 0/33 3/22 3/55 0.049 
 Myoclonic 6/33 12/22 18/55 0.0075 
Focal seizures (n) 6/33 6/22 12/55 0.33 
Spasms (n) 9/33 3/22 12/55 0.50 
Therapies at time of surgery     
 Median AED (IQR) (n) 3 (1) 3 (2) 3 (1) 0.37 
 Active VNS (n) 2/33 0/22 2/55 0.52 
Median follow up (IQR) 
(months) 
33 (34) 42 (30.25) 36 (34) 0.52 
 
In total, 4/55 patients prior to surgery had only drop attacks prior to surgery, 9/55 
patients had drop attacks plus one other type of seizure prior to surgery, 22/55 
patients had drop attacks plus two other types of seizure prior to surgery, and 
20/55 patients had drop attacks plus at least three other types of seizure prior to 
surgery.  
 
All patients had some degree of developmental delay (n=55); 49 patients had 
moderate-severe global developmental delay. Structural brain abnormality was the 
most common known epilepsy aetiology (n=15). Other aetiologies included 
genetic (n=8), infectious (n=3) and immune mediated (n=1).  
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Comorbidities other than developmental delay included Cerebral Palsy (CP; 
n=10), Autism Spectrum Disorder (ASD; n=10), Attention Deficit Hyperactivity 
Disorder (ADHD; n=8) and sensorineural hearing loss (n=2). Three patients had 
two comorbidities other than developmental delay (CP with ASD, CP with ADHD, 
and ASD with sensorineural hearing loss). Known aetiologies were found in 17/28 
patients with a comorbidity other than developmental delay, compared with 8/25 
patients without a comorbidity other than developmental delay. 
 
Abnormalities on MRI classified according to the Barkovich classification included 
Group I (tuberous sclerosis, n=2; focal cortical dysplasia, n=1), Group II 
(lissencephaly, n=1; subcortical band heterotopia, n=3), Group III 
(polymicrogyria, n=4). Other abnormalities included PVL (n=2), HIE (n=2), 
damage secondary to infection (HSV, n=2; abscess, n=1), loss of grey-white 
differentiation (n=2). 
 
Only one GOSH patient had a chromosomal abnormality, which was a ring 
chromosome 20, otherwise karyotyping revealed no chromosomal abnormality. 
The only genetic defect found in CHW patients was MeCP2 duplication (n=3); one 
of these patients had a structural cause of their epilepsy, namely subcortical band 
heterotopia. Four distinct genetic defects were found in GOSH patients: 
17q22/17q23.2 deletion (n=1), TSC2 (n=1), COL4A1 (n=1) and 1p36 deletion 
(n=1); the patient with TSC2 was reported as having a structural cause, namely 
tuberous sclerosis. There were two patients with Sturge-Weber syndrome; neither 
patient was formally tested, but the syndrome is known to be caused by somatic 
mutations in GNAQ. 
 
3.2 Tolerability 
Neurological complications occurred in 20.8% of surgeries and all resolved within 
6 weeks. These included: hemiparesis (n=7), disconnection syndrome (n=2), gait 
ataxia (n=1) and aphasia (n=1). Disconnection syndrome occurred in one patient 
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with anterior corpus callosotomy and one patient with complete corpus 
callosotomy; there was no significant difference (p=0.37). These resolved by the 
time of the initial post-surgical follow up. 
 
Minor surgical complications occurred in 11.3% of surgeries and included 
intracranial haematoma that did not require surgical evacuation (n=2), pyrexia 
(n=2) and intracranial infection (n=1). The only major complication was 
hydrocephalus (n=1) and there were no deaths.  
 
There was no significant difference in complications between anterior corpus 
callosotomy and complete corpus callosotomy (minor neurological 1/11 vs 6/43, 
p=0.67; minor surgical 1/11 vs 4/43, p=1.0; major surgical 0/11 vs 1/43, p=1.0). 
 
3.3 Primary Outcome 
Median follow up post-surgery was 36 months (interquartile range (IQR) 34 
months, range 7-131 months). Figure 3.1 shows the frequency of drop attacks pre-
surgery and at last follow up.  
 
 
Figure 3.1 Frequency of drop attacks pre surgery and at last follow up. 
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Overall, 26/55 patients achieved a good outcome for drop attacks at last follow up. 
Of the children with a poor outcome for drop attacks, 26/29 of these patients had a 
return of drop attacks within 12 months of surgery. The Kaplan-Meier survival 
curve of good outcome of drop attacks is shown in Figure 3.2. This shows the 
number of months post-callosotomy that patients had a worthwhile reduction in 
drop attacks.  
 
 
Figure 3.2. Kaplan-Meier survival curve of good outcome for drop attacks 
 
Logrank statistics for clinical features are shown in Table 3.2. None of the clinical 
features reached statistical significance. 
 
 
 
 
Corpus Callosotomy Outcomes in Paediatric Patients 
64  David Graham - March 2018 
Table 3.2. Logrank statistics for clinical features associated with good outcome. 
Clinical feature Logrank p 
Age at epilepsy onset < median age at 
onset 
0.6495 
Age at surgery < median age at surgery 0.4926 
Tonic drop attack 0.2099 
Total corpus callosotomy 0.1564 
LGS spectrum 0.8161 
Moderate-severe developmental delay 0.8567 
Abnormal MRI 0.4057 
 
A landmark analysis is shown in Figure 3.3. It assesses the effect of an initial good 
drop attack outcome period of 12 months (the “cutoff period”). Two groups are 
considered with this approach: 1) all patients (ie the results of Figure 3.2); and 2) 
patients who are right-censored beyond the cutoff period or who have drop 
attacks return after that period. Kaplan-Meier survival curves of these two groups 
of patients are compared using logrank statistics.  
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Figure 3.3. Landmark analysis 
 
The results for cutoff periods of 12, 18 and 24 months are shown in Table 3.3 
including the proportion of patients who continue to have good drop attack 
outcomes following the cutoff period. The results are not significant when the 
cutoff period is 6 months (p=0.074). 
 
Table 3.3. Logrank statistics for initial seizure free period 
Initial period of good drop 
attack outcome 
Proportion of patients 
who continue to have 
Engel class I-II outcome 
Logrank p 
12 months 0.81 <0.0001 
18 months 0.83 <0.0001 
24 months 0.95 <0.0001 
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In summary, 26/55 patients (47.3%) were either free of drop attacks or continued 
to have rare drop attacks at last follow up. Of the remaining 29 children, 26/29 
patients (89.7%) had a return of drop attacks within 12 months of surgery. 
 
3.4 Secondary Outcomes 
3.4.1 Injuries from Drop Attacks 
There was a significant reduction in the number of patients who were sustaining 
injuries between clinic appointments due to their drop attacks (pre-surgery 77.4% 
vs last follow up 20.8%, p<0.0001). Among patients who continued to have drop 
attacks at the time of last follow up, there was also a significant reduction in the 
number of patients sustaining injuries (pre-surgery 73.1% vs last follow up 42.3%, 
p=0.048). This is shown in Figure 3.4. 
 
 
Figure 3.4. Proportion of patients who sustain injuries from drop attacks pre 
surgery and at last follow up 
 
3.4.2 Other Seizures 
In total, 4/55 patients prior to surgery had only drop attacks prior to surgery, 9/55 
patients had drop attacks plus one other type of seizure prior to surgery, 22/55 
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patients had drop attacks plus two other types of seizure prior to surgery, and 
20/55 patients had drop attacks plus at least three other types of seizure prior to 
surgery. Patients with one other seizure type were significantly more likely to 
achieve a good outcome for other seizures compared with patients with two other 
seizure types or three or more other seizure types (100.0% good outcome for 
other seizures vs 22.7%, p=0.0084; 100.0% vs 10.0%, p=0.0014). However, the 
outcome for drop attacks was not statistically significantly associated with the 
number of other seizure types. The overall outcome and frequency of other seizure 
types is shown in Figure 3.5.  
 
 
Figure 3.5. Outcomes for other seizures. Panel (a) shows frequency of other seizures 
before surgery and at last follow up; panels (b) and (c) show good outcomes for 
differing pre-surgical number of other types of seizure: (a) outcomes for other 
seizure types stratified for number of other seizure types; (b) drop attack outcomes 
stratified for number of other seizure types. 
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3.4.3 New Seizures 
A total of 7/55 patients experienced the onset of new onset partial seizures at last 
follow up and 3/55 patients experienced the onset of new generalised seizures at 
last follow up. This is shown in Table 3.4 comparing good outcome for drop attacks 
to patients with poor outcome for drop attacks. There were no statistically 
significant differences. 
 
Table 3.4. Number of patients experiencing new seizure types at last follow up. 
 Good drop attack 
outcome (n=26) 
Poor drop attack 
outcome (n=29) 
p 
Any other seizure 7 3 0.16 
Generalised seizures 2 1 0.60 
Partial seizures 5 2 0.24 
 
3.4.4 Neuropsychological changes 
All 55 patients had formal neuropsychological assessment as part of the workup 
for epilepsy surgery. Formal neuropsychological assessment was performed in 
3/55 patients, each of whom had developed anxiety (n=2) or a mood disorder 
(n=1). Neuropsychological changes at last follow up were therefore not included 
as post-operative formal assessment were only conducted if clinically indicated.  
 
3.4.5 Neurophysiological changes 
Neurophysiology findings were initially included and Hanson et al’s classification 
system was initially applied post-hoc. The validity of this post-hoc approach was 
questionable for this present retrospective study and so was abandoned. A 
complete review of all EEG and VEEG data would be required, rather than a review 
of reports only, in order for this approach to be valid. Such a review was beyond 
the scope of this thesis. Moreover, post-operative neurophysiological studies were 
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only conducted in 30/55 patients (54.5%) when clinically indicated due to changes 
in seizure semiology. Consequently neurophysiological findings were not included 
as outcomes. Including Hanson et al’s classification system would be beneficial in a 
prospective study, but poses challenges in a retrospective study. 
 
3.4.6 Antiepileptic Drugs 
The median number of AEDs used at last follow up was 2 AED (IQR=1). Mann-
Whitney’s U test showed this was significantly fewer than the pre-surgery median 
number of 3 AEDs (IQR=1) (p=0.0018). 
 
3.5 Multivariable Regression Analysis 
Multivariable logistic regression analysis of good outcome for drop attacks using 
backward selection had a Harrell C-statistic of 0.66 and a maximum rescaled R2 
value of 0.14. None of the clinical features described in the method reached 
statistical significance as predictors of good outcome. The results of the analysis 
are shown in Table 3.5.  
 
Table 3.5. Multivariable logistic regression analysis of good drop attack outcome at 
last follow up. 
Clinical feature p 
Age at epilepsy onset (years) 0.75 
Age at surgery (years) 0.70 
Tonic drop attack 0.25 
Total corpus callosotomy 0.12 
LGS spectrum 0.98 
Moderate-severe developmental delay 0.51 
Abnormal MRI 0.68 
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3.6 Discussion 
Despite a wide variation in patients in this present case series on paediatric 
outcomes of corpus callosotomy, there were very few differences between the two 
centres. All patients had some degree of developmental delay, with the majority 
having moderate-severe developmental delay and almost half of the patients 
having at least one other comorbidity. Lennox-Gastaut Syndrome, West Syndrome 
and Ohtahara Syndrome were the most common syndromes. All patients had been 
investigated with MRI as part of their workup, 30/55 patients (54.5%) had a 
structural abnormality. Genetic causes were found in 8/55 patients (14.5%), 
namely Stuge-Weber syndrome (GNAQ; n=2), MeCP2 deletion (n=2), Ring 
chromosome 20 syndrome (n=1), 1p36 deletion syndrome (n=1), 17q22/17q23.2 
deletion (n=1), COL4A1 (n=1). 
 
3.6.1 Tolerability 
Corpus callosotomy was well tolerated regardless of extent of callosotomy. The 
complication rate in our series was comparable to the paediatric literature5. Bjellvi 
et al’s prospective, population-based study perhaps provides the best evidence of 
complications after epilepsy surgery and they use a similar classification system to 
ours84. They observe that the complication rate may be under-reported in the 
literature as most studies are retrospectively designed. Although the Bjellvi et al 
study is limited to a single country and only 24 corpus callosotomies were 
performed on paediatric patients, they found that 0/24 patients developed a minor 
complication and 1/24 patients developed a major (unspecified) complication84.  
 
Notably the findings in our series for disconnection syndrome differ from the 
literature. While the literature suggests that approximately 12% of paediatric 
patients will experience a transient disconnection syndrome, which is significantly 
more likely in complete corpus callosotomy (p<0.0001) (Graham 2016), our 
series found disconnection syndrome was uncommon (only 1/55) nor was there 
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any significant difference in outcome for complete versus anterior corpus 
callosotomy (p=0.37). This may in part be due to the fact that extent of callosal 
section in our series was largely based on intraoperative surgeon’s report.  
 
Transient hemiparesis is a common complication in the literature5 and it was the 
most common complication in our series (13%). There are two hypotheses to 
account for the reversible hemiparesis. The usual assumption is that it is 
associated with the retraction of the contralateral leg motor area during surgery. 
This hypothesis could be confirmed with diffusion weighted imaging. However it is 
also possible that the hemiparesis is due to the interruption of venous drainage 
relating to the division of central cortical veins in order to gain access to the 
interhemispheric fissure. This alternate hypothesis could be confirmed with a 
study that investigates any relationship between the number of veins divided 
during surgery and any post-operative deficits. 
 
3.6.2 Drop Attacks 
The outcome for drop attacks at last follow up was poorer than the paediatric 
literature5, which may be due to the longer follow up than the reports in the 
paediatric literature. This was observed by Tellez-Zenteno in their review in which 
they found the effect of corpus callosotomy diminishes beyond 5 years74. Our 
multivariable logistic regression analysis showed that there was a significant effect 
of at least 12 months of worthwhile benefit of corpus callosotomy on drop attacks 
(p<0.05). Indeed, 81% of patients who did have a return of drop attacks did so 
within 12 months of follow up, similar to the case series by McInerney et al85, 
which is a clinically valuable finding. Moreover, patients who continued to have 
drop attacks following surgery were less likely to sustain injuries, which supports 
the use of corpus callosotomy for palliation of patients with drop attacks. 
Stigsdotter-Broman et al’s long term population-based study found sustained 
benefit for 56% of patients out to 10 years post-surgery75. This may suggest that a 
good drop attack outcome at 12 months could be a clinically valuable post-surgical 
marker for sustained good drop attack outcome. Interest is also turning towards 
selective posterior corpus callosotomy, with Paglioli et al’s recent study finding 
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30/36 patients were either free or almost free of drop attacks at last follow up54. 
However, this must be contrasted with Pinard et al’s older study in which all of the 
patients who underwent posterior corpus had poor outcomes53. 
 
No clinical factors were associated with a significant effect on the outcome of drop 
attacks. Extent of callostotomy is the factor that is most commonly associated with 
seizure outcome in the literature5, however our series found no significant effect of 
extent of callosotomy. This may be due to a combination of factors, such as the 
relatively smaller number of partial corpus callosotomy patients in our case series, 
and the fact that extent of callosotomy was not solely based on post-operative 
imaging.  
 
To date, all studies of corpus callosotomy outcomes in paediatric patients have 
focused on outcome at last follow up5. This is the first study of corpus callosotomy 
to investigate the temporal aspect of Engel class outcome for drop attacks. The 
regression analysis accounts for approximately 14% of the variance in drop attack 
outcome and the explanatory power of regression models has not previously been 
reported in the paediatric corpus callosotomy literature5. Finally, this is one of the 
largest study of corpus callosotomy in the paediatric population5,61,63, which 
highlights the value of combining outcomes between centres. 
 
3.6.3 Other Outcomes 
There were significantly fewer AEDs used at last follow-up compared with the pre-
surgery (p<0.05), which is different to the paediatric literature5. This may reflect a 
strategy for optimising AED usage in order to reduce the number of side effects but 
it could explain the relatively poorer outcome for drop attacks compared with the 
literature. However the complex interplay between corpus callosotomy, optimal 
medical management, and AED side effects is beyond the scope of this thesis and 
has not been explored in the literature. 
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The benefit on other seizures was generally poor, and was not correlated with 
drop attack outcome. It is not entirely clear whether the emergence of new seizure 
types is a reflection of the impact of the surgery or the evolution of the epilepsy. 
However, patients who had only one other seizure type benefited from corpus 
callosotomy for both drop attacks and the other seizure type. This may be 
indicative of the severity of seizure semiology prior to surgery, which, if 
appropriately defined, could prove to be another clinically relevant prognostic 
marker.  
 
3.6.4 Limitations 
The key weakness of this study is its retrospective case series design. This may 
lead to the inaccurate reporting of some data such as the full seizure semiology, 
any injuries from drop attacks, and the neuropsychological impact. It is for this 
reason the EEG characteristics could not be included for analysis even though slow 
ictal and interictal spike-wave patterns and reduced synchronicity of post-
operative discharges have been reported as prognostic features of a good 
outcome34. While this introduces bias into the results, the study is useful as it does 
identify new information about the durability of seizure outcomes, and supports 
the hypothesis that corpus callosotomy is a safe and effective palliative treatment 
for paediatric patients with generalised seizures characterised by drop attacks.  
 
There are potential centre differences in patient selection, workup and surgical 
approach. While both centres use ILAE recommendations for referral and 
evaluation80, there may be differences prior to 2006. 
 
3.6.5 Future Directions 
As discussed elsewhere in the literature5,86, there is a clear need for a randomised 
control trial (RCT) of corpus callosotomy outcomes. The design of such a trial has 
been outlined by Graham, Tisdall and Gill in their systematic review5 based on 
Wiebe et al’s landmark RCT of temporal lobectomy73. This is expanded in Appendix 
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A. Dwivedi et al have published the results of their RCT on epilepsy surgery, which 
includes a corpus callosotomy group72 and is discussed in section 1.3.2 above. 
However the study does not reflect the palliative nature of corpus callosotomy. 
Indeed, a good outcome in Dwivedi’s study is defined as seizure freedom72, which 
is not expected with corpus callosotomy. Moreover, there is no distinction between 
partial or complete corpus callosotomy72. 
 
The prognostic benefit of an initial 12 month period of worthwhile benefit on drop 
attacks identified in this thesis could aid the design of such a trial. A prospective 
design would allow for imaging to confirm the extent of the callosotomy, and could 
include recording the number of emergency and intensive care admissions for 
injuries and other complications of epilepsy. However, enrolling a sufficient 
number of patients will be challenged by the relative infrequency of corpus 
callosotomy. Moreover there may be limited enrolment given the challenges faced 
by parents in consenting to corpus callosotomy following extended periods of 
optimal medical management. Imaging studies comparing semiology of drop 
attacks as well as other seizures pre and post callosotomy may provide some 
insight into the seizure outcomes reported here and elsewhere. They have 
potential to provide insight into the long-term tractographic changes post-
callosotomy, as well as why reported outcomes in children are generally better 
than those of adults. 
 
Advances in neuroimaging and bioinformatics are providing insights into the 
interactions between neurons and behaviours emerging from their connectivity. 
This has opened up the new field of connectomics, which is the study of maps of 
connections within a nervous system called connectomes. This can be studied from 
a structural or functional perspective, or at the local circuit level. Engel et al have 
recently speculated that therefore epilepsy research could benefit from 
connectomics21. While connectomics provides insight into the pathogenesis of 
generalised seizures, its value in epilepsy surgery is yet to be established. Callosal 
volumes can be explored in prospective studies, with a view towards simple 
prognostic biomarkers. But deeper investigations into connectomics may be of 
benefit. Recent work suggests a potential benefit from posterior corpus 
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callosotomy based on more favourable connectomics54. Yet there remains many 
unanswered questions, such as: why do children have only transitory neurological 
complications5? Or, why can drop attacks return following total corpus 
callosotomy? A deep connectomics study could help illuminate these questions. 
 
Psychiatric conditions and developmental delay are common in children with 
refractory epilepsy. Indeed, there is evidence to suggest that there may be a close 
relationship between psychiatric disorders and epilepsy, with multiple complex 
biopsychosocial factors at play87. This highlights the need to use a biopsychosocial 
perspective on the outcomes of disconnective epilepsy surgery. The 
neuropsychiatric complications of epilepsy may have a greater negative impact on 
quality of life than seizure frequency88,89. The neuropsychiatric outcomes of 
resective epilepsy surgery are well-understood, with patients experiencing some 
cognitive benefits90. However, the neuropsychiatric outcomes of disconnective 
epilepsy surgery are poorly understood5. This is especially important in the 
paediatric population as generalised epilepsies have their highest incidence in 
children. While formal neuropsychiatric review is an important part of the workup 
for epilepsy surgery, to date there have been no systematic reviews of the 
neuropsychiatric outcomes of disconnective epilepsy surgery in the paediatric 
population. 
 
Finally, there is growing interest in the health economics of epilepsy in general, 
with some insights already being made into the health economics of epilepsy 
surgery37,91. Powerful insights into the mechanisms behind the relationship 
between socioeconomic factors and disease are emerging through the use of health 
economic theory. But the mechanisms that underlie the relationship between 
socioeconomic factors and disability are unclear. Microeconomic theories of health 
capital such as the Grossmann model have consistently supported the 
disentangling of these mechanisms92. In so doing, such an approach to the health 
economics of epilepsy surgery could improve our understanding of how best to 
target the costs and access of treatment. Moreover a microeconomic approach 
would introduce rigour to the modelling beyond cross-sectional studies, but this 
approach has yet to be used despite the clear need91,93. 
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4 BIOETHICAL ISSUES 
From a clinical standpoint, corpus callosotomy is likely to be a highly effective and 
safe procedure that should be conducted before adulthood5,37,66. The risk of 
transient complications and the so-called “burden of normality” can be adequately 
managed in hospital and through multidisciplinary post-surgical rehabilitation as 
well as engagement with the family’s general practitioner. But parents are faced 
with the challenge of weighing up uncertain success with the possibility of 
disconnection syndrome and other neurological complications, however unlikely.  
 
Any paediatric epilepsy surgery therefore raises questions about access to, and the 
bioethics of, corpus callosotomy in particular, and epilepsy surgery in general. 
Resective and disconnective epilepsy surgery conjures up a dubious history of 
lobotomies in the 1950s. The permanent disconnection syndromes suffered by the 
commussureotomy patients further charges these images, and presents a challenge 
to parents. But times have changed and the reality of epilepsy surgery in 2017 is 
vastly different. 
 
This chapter presents a clinical case of a child with frequent drop attacks but with 
average intelligence. While most corpus callosotomy patients have moderate to 
severe developmental delay, patients with average intelligence do exist such as in 
Cendes et al’s case series65. A patient with average intelligence has been chosen in 
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order to frame some issues relating to access, consent and the best interests of 
paediatric epilepsy surgery patients. 
 
4.1 Case Presentation 
SL is a 15 year old girl of average intelligence with generalised seizures that is 
characterised by weekly generalised tonic-clonic seizures and daily drop attacks, 
many of which cause injury. Notably, her epilepsy is refractory to medical 
treatment. SL is currently seen in the Epilepsy Clinic at CHW.  
 
Her past medical history is otherwise unremarkable. She was born by an 
uncomplicated normal vaginal delivery. Her mother was healthy throughout the 
pregnancy and all antenatal screening was normal. Her immunisations are 
currently up to date. SL has achieved all of her developmental milestones and her 
neuropsychological assessments show no significant deficits, with an FSIQ of 95.  
 
SL attends high school where she has a wide circle of friends, but she still becomes 
embarrassed when she has a drop attack despite her good social supports, and will 
often take several days off school as a result. She lives with her parents, who are 
first generation migrants from China, and her younger brother. There is no known 
family history of epilepsy, though there is significant amount of stigma from her 
relatives in China, so it is not clear if there are any relatives in China with epilepsy. 
 
SL’s seizure history is shown in Table 4.1. The drop attacks have proved to be 
difficult to control despite a trial of Lamotrigine. SL now has daily drop attacks 
despite maximal doses of Sodium Valproate and Topiramate.  
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Table 4.1. SL’s seizure history 
Age Semiology Frequency Treatment Response 
4 Myoclonic jerks Daily 
Sodium 
Valproate 
Controlled 
6 GTCS 
Infrequent, 
increasing to 
daily 
Carbamazepine Weekly 
12 
Tonic seizure 
and tonic drop 
attacks 
Daily Topiramate 
Tonic seizures 
controlled, drop 
attacks remain 
daily 
13 
Tonic drop 
attacks 
Daily 
Trial of 
lamotrigine 
Nil benefit 
 
 
SL has presented to CHW emergency department every two to three months over 
the period 2014-2016 for injuries sustained from her drop attacks. These have 
mostly been head injuries, especially to the face and nose, requiring sutures. She 
has had two broken noses and a fractured left orbit, and has lost three teeth. This 
has caused SL and her family distress and is impacting her attendance at school 
even though she has a strong social support network.  
 
SL’s parents were offered a total corpus callosotomy for palliative treatment of her 
epilepsy in 2016, but they expressed concern about the possibility of permanent 
neurological complications, especially disconnection syndrome. The nature and 
likelihood of these complications, as well as the balance of benefits of corpus 
callosotomy, were discussed at length with SL’s parents. The topic was broached at 
each of her six monthly clinics, with new evidence presented, such as Graham, 
Tisdall and Gill’s systematic review5, or the combined CHW and GOSH case series 
by Graham et al76. Indeed, her parents requested copies of the literature to 
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consider when they returned home to discuss at the following clinic. Despite 
careful communication, SL’s parents redirected the dialogue to disconnection 
syndrome and continue to refuse treatment. 
 
4.2 Access 
The decision to progress with a corpus callosotomy is a relatively straightforward 
clinical one, but SL’s case raises questions about the bioethics of corpus 
callosotomy in particular, and epilepsy surgery in general. Ibrahim et al argue that 
an ethical framework of epilepsy surgery ought to be based on access, protection of 
vulnerable patients, transparency, equity despite inequality, and societal benefit94. 
As early intervention is important, access is axiomatic to the clinical ethics of 
epilepsy surgery95. Parental resistance is a common barrier to access for epilepsy 
surgery, however education has been shown to mitigate this barrier96.  
 
Patients with disabilities require complex management and access a wider range 
of services than non-disabled patients97. Making sense of these services is 
important for good patient outcomes. Raynor argues that it is not only important 
to remove barriers to understanding by using plain language, but to also remove 
the complexities of healthcare systems98. This is especially true for patients with 
disability. While children with disability require more frequent access to health 
services, their ability to access these services may in fact be more limited than 
healthy normal children99. Equity and access, especially in relation to education, 
are vital for the health of children with a disability99. 
 
The family general practitioner (GP) is important for improved outcomes for 
children with a disability100. Nevertheless, access relies on a partnership between 
parents and practitioners. As a child under the age of 16, the decision to divide SL’s 
corpus callosum rests with her parents unless she satisfies the Gillick test. An 
adolescent of normal intelligence makes SL a unique corpus callosotomy patient. A 
typical corpus callosotomy patient will have a number of co-morbidities including 
cerebral palsy and autism, and are usually severely developmentally delayed. This 
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is not the image SL’s parents see when they think of her daughter, but despite her 
uniqueness in this very unique community, SL is not a mature minor. SL’s 
uniqueness needs to be considered in sensitively representing the clinical 
standpoint to her parents – discussing the outcomes seen in the corpus 
callosotomy patient population may not be compelling to them.  
 
4.3 Consent 
Consent is at the heart of patient-centred care. It signifies the active participation 
of patients in their health. In its simplest terms, consent means that a patient freely 
agrees to the healthcare provider to infringe upon certain rights, such as the right 
not to be assaulted in order to undergo surgery101. The elements of a valid consent 
essentially include:  
1. Validity: the patient must voluntarily enter a “contract” with the healthcare 
provider, for which competence must be tested; 
2. Information: the healthcare provider must disclose the risks and benefits of 
the intervention, and the patient must unequivocally understand them; and  
3. Enaction: the consent must be specific to the intervention and the patient 
must authorise the healthcare provider to carry out the treatment. 
 
But consent is fundamentally an ethical concept with an imperfect practical 
application. Consequently it is often over-shadowed by legal discussions in order 
to make sense in the clinical setting101. I believe the legal discourse reflects the 
ethics of consent. In the landmark case of Rogers vs Whitaker (1992) 175 CLR 479, 
the court focused on two key elements to consent in its judgment: self-
determination and disclosure of risk101. Rogers vs Whitaker requires that 
information be provided in a patient-focused manner rather than a clinician-
focused manner. The intent is to allow the patient to exercise their self-
determination to balance the personal risks with the patient’s own goals101.  
 
Clearly obtaining consent is open to question in clinical practice, highlighting the 
practical limitations of consent. More fundamentally, Schneider suggests that the 
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requirement for informed consent demands a “mandatory autonomy” rather than 
respects patient autonomy, which has been described by Davies and Elwyn as the 
“paradox of imposing choice upon patients” (as cited in Manson (2010)102, p 834).  
 
It is important to remember that ethics is not merely morals. Medical ethics is 
guided by the principles of beneficience, nonmaleficience, autonomy and justice101. 
As noted above, the ethics of consent tends to assume and concern the autonomy 
of a patient, but the meaning of autonomy has a long history of debate103. O’Neill 
observes that most contemporary accounts of autonomy reduce the concept to a 
discussion of independence rather than its ethical significance103.  
 
There is much in the philosophy of autonomy that essentially begins with Kant’s 
philosophy of practical reason. Kant’s philosophy of practical reason concerns our 
ability to use reason to freely choose our own actions104. Kant argued that moral 
laws that guide our own actions can only limit our freedom if those laws are acts of 
our own will; autonomy is the self-imposition of the moral law. In his utilitarian 
philosophy, Mill elevated autonomy to something of intrinsic value in itself 
separate from Kant’s practical reason105. This utilitarian conception arguably lays 
the foundations for the principle of autonomy in modern medical ethics.   
 
Contemporary Kantian philosophers view autonomy as a measure of self-worth 
whereby one must be able to trust one’s own capacity to make a decision and 
accept responsibility106-108. This is perhaps easier to digest Kant’s ideas of 
autonomy, but tends to dilute the essence of Kant’s autonomy. However autonomy 
is not universally accepted among ethicists, with Hegel and Nietzsche being 
notable examples who had a strong influence on 20th century philosophy. Their 
critiques essentially concern the assumption of universal laws as they develop 
their pluralistic conceptions of meaning (see for instance Deleuze (2006)109, 
Foucault (1988)110), with Foucault famously stating that “there is no sovereign, 
founding subject, a universal form of subjects to be found everywhere” (Foucault 
(1988) 110, p50). Short of suggesting patient-centred care is philosophically flawed, 
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we can at least agree that if consent is founded on autonomy, then it is 
understandable why it is fertile ground for debate and a subject of common law. 
 
O’Neill argues that, regardless of the meaning of patient autonomy, consent 
fundamentally concerns coercion and deception on the part of the clinician103. This 
detaches the concept of informed consent from a philosophically shaky assumption 
and returns it to a more pragmatic setting that is reflected in the fundamental 
requirement by Rogers vs Whitaker to disclose risk to the patient. It is important 
to begin a reframing of consent independent of autonomy as bioethics in the 21st 
century shifts its emphasis from autonomy to justice111. In my mind, this leaves 
open the way for other aspects of consent that frame it in a more humane light.  
 
Indeed, the emphasis on autonomy is sociocultural not universal. An alternate 
viewpoint to autonomy is that healthcare decisions should be based on the 
provision of care and compassion. After all, autonomy (framed as independence) 
diminishes the importance of caring and interdependence, which arguably is what 
a vulnerable patient craves101. Kopelman argues that consent can never be 
completely rational in the face of mortality or uncertain outcomes112. It is therefore 
perhaps more useful to view consent as a request for help rather than an 
agreement to proceed with an intervention that ostensibly infringes a patient’s 
rights113. Consent is not necessarily an exercise in rational choice, which would be 
a Kantian interpretation, but instead introduces the emotional quality of medical 
decision-making. O’Neill argues that consent is a proposition that describes the 
action to be performed, but that it is opaque as the logical consequences of my 
consent may not be transparent to the patient103. This is the basis of his position 
that consent concerns coercion and deception, and he cites events at two hospitals 
in the UK.  
 
Rogers vs Whitaker recognises that full disclosure is impractical, which is 
consistent with O’Neill’s position, but it also recognises that communication is 
axiomatic to the determination of what is relevant for the patient. While the details 
of epilepsy surgery and its complications can readily be communicated, the 
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neuropsychological sequelae of epilepsy surgery aren’t fully understood5. So there 
is indeed opacity to the consent for epilepsy surgery and the circumstances, and 
gaps in clinical research make it difficult to fully disclose every detail that would be 
relevant to a particular patient.  
 
While consent is at the heart of patient-centred care, not all patients want to take 
part in decision-making114. Despite this, patients still wish to be informed and 
Manson argues that this should come as no surprise102. He suggests several 
reasons why this is the case: patients want to make decisions, but not about 
treatment; patients want respect and providing information is a mark of that 
respect; patients want to be psychologically and emotionally prepared; patients 
want to know the reasons behind a certain course of action; communicating 
information is a marker for the trustworthiness and competence of the clinician 
and that they have deliberated alternatives and weighed up risks; patients want 
the opportunity to ask questions and seek clarification. It seems that information is 
necessary for the involvement in decision-making, but it is not sufficient. This is 
consistent with most ethical positions103. 
 
When consent becomes ethically charged, a framework for ethical reasoning can be 
useful. Kaldjian, Wier and Duffy propose a systematic strategy for clinical ethical 
reasoning that parallels clinical reasoning115. They argue that their approach 
incorporates ethical plurality by explicitly stating a “differential diagnosis” that is 
used in forming an ethical assessment. In order to arrive at the “differential 
diagnosis,” the medical facts, medical goals, patient goals and the context are 
elucidated. In the context of consent, their approach essentially highlights that 
consent is more than patient autonomy and in the practical setting can be viewed 
as an evolving discourse between patient and clinician. Thus, the interpersonal and 
transitional nature of consent can be established in a practical setting using this 
type of strategy rather than remain in the domain of ethics. This is also reflected in 
other approaches, such as Jonsen, Siegler and Winslade’s IDEA framework 
(Identify the facts, Determine the relevant principles, Explore the options, Act)116. 
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4.4 Best Interests 
Children represent a special population for whom surrogate-decisions are made on 
their behalf by their parents. The medicolegal test for any paediatric intervention 
is based on the concept of best interests. Consider Marion’s case (ie Secretary of 
the Department of Health and Community Services v JWB and SMB [1992] HCA 
15), which is the test case for “best interests” in Australia101. The High Court of 
Australia found that, while parents may consent to medical treatment on behalf of 
a child, they must act in the best interests of their child. In Marion’s case, surgical 
sterilisation was not deemed to be in her best interests, but instead served the 
interests of her parents. On the balance of risks and benefits, a corpus callosotomy 
is clearly therapeutic and is likely to prevent injurious drop attacks as well as 
improve life expectancy. Any benefit to the parents is secondary so they can legally 
consent to a corpus callosotomy on behalf of their child.  
 
Best interest decisions involve the moral principles of beneficience and 
nonmaleficence101. These are not universal principles, but neatly represent the 
moral grounds that guide the delivery of medical care. As they do represent a 
moral position, they can be a source of ethical conflict in themselves and are 
important therefore in consent. The standard of best interest decision-making is 
patient-centred and focused on the current needs of the patient117. But such 
decisions will always be entangled with the interests of others. 
 
The autonomy of the child is deferred to the parent. The ethical difficulties with 
autonomy that I previously discussed are further complicated by the child’s best 
interests. Under common law, the decision to undergo epilepsy surgery in a child 
under the age of 16 rests with the parents unless the Gillick test is satisfied. As 
noted above, parents of corpus callosotomy patients generally report satisfaction 
even when outcomes have been poor5. While parental resistance can pose a health 
literacy challenge, parental resistance in child health is ostensibly a legal barrier. 
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Are SL’s best interests best served by corpus callosotomy or by continuing with the 
current therapy regime? Only one published paper has included details of a corpus 
callosotomy patient with normal intelligence like SL5,65 and it is worth considering 
the case in this discussion. Cendes et al describe Patient 21, a 14 year old female 
with normal intelligence who developed epilepsy at the age of 465. She underwent 
a two-stage total corpus callosotomy with division of the anterior commissure, 
which resulted in >75% reduction in all seizure types and cognitive improvement. 
Patient 21 returned to school following recovery and had improved performance 
at school at 33 months follow up65. It seems that the atypical Patient 21 had an 
outcome that was typical of a good outcome of corpus callosotomy. 
 
While this anecdotal evidence seems hopeful, doubt still remains in the minds of 
SL’s parents. Communicating the clinical evidence has not been sufficient to lift the 
barriers. If SL were to develop complications, her parents will have to live with the 
knowledge that they gave consent to a procedure that permanently damaged their 
daughter’s brain. This blunt and crude reality would be difficult to live with. Does 
the unlikely event of permanent disconnection syndrome or a shunt for 
hydrocephalus outweigh a good chance at improvement in drop attacks? 
 
A surrogate decision made in a child’s best interests would ideally provide the 
maximum benefit to the child. Parents may refuse on the grounds that intervention 
is futile or offers uncertain benefits. In the case of SL, the uncertainty potentially 
lies in the tension between a 90% chance of a worthwhile improvement in drop 
attacks following irreversible brain surgery. To be sure, individual circumstances 
are important and SL’s parents may feel that preventative measures may be 
sufficiently effective that drop attacks do not significantly impact the quality of her 
life.  
 
4.5 Health Economics 
The healthcare needs of a child with a disability require significant resources that 
are delivered by multiple services in Australia. Disability encompasses a 
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heterogeneous mix of conditions that each have different aetiologies and natural 
histories. A broad definition of disability should align with the International 
Classification of Functioning, Disability and Health for Children and Youth (ICF-
CY)118. In this framework, disability includes patients with a chronic physical, 
developmental, behavioural or emotional condition that requires health services 
beyond children in general, including specialist and disability services. But 
consideration of the impact of the healthcare system and family relationships on 
the child is an important perspective that should be kept in mind119.  
 
Understandably, a child with a disability may therefore have needs that require 
additional personal resources in order to access these services. Children with a 
disability also rely more heavily on parents, siblings, other family members and 
teachers for assistance120. Indeed a parent may need to take on full time caring 
responsibilities. Payments for Australian carers are less than half the median full-
time income 118,121, so it is evident that there is potentially a negative impact of a 
child’s disability on family income in spite of the support available. Disability also 
impacts a child’s potential employment and education opportunities and even 
though disability is more prevalent in boys than girls, young women report greater 
limitation in ADL than young men122.  
 
Cross-sectional studies in Australia highlight there is no significant effect of 
remoteness on childhood disability in Australia, but Aboriginal and Torres Strait 
Islander (ATSI) children are significantly more likely to develop a disability than 
non-Indigenous children123. It is not clear however whether this effect is due to 
higher rates of socioeconomic disadvantage in the ATSI population as data is 
limited.  
 
The Longitudinal Study of Australian Children (LSAC)16 and the Longitudinal Study 
for England and Wales17 are the first studies that include children with a disability 
in their cohort design. These landmark studies used household income to test 
socioeconomic disadvantage and its impact on childhood disability and found that 
children born into the lowest income quintiles were significantly more likely to 
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develop a disability16,17. Spencer and Strazdins’s analysis of LSAC found that 
household income was negatively impacted by the onset of disability in a child, 
demonstrating a bi-directional relationship between socioeconomic disadvantage 
and the development of disability in children16. If socioeconomic disadvantage is 
also a determinant of disability, then existing disadvantage is further compounded 
once a child develops a disability.  
 
This complexity poses a challenge to the healthcare system and begs the question 
of how can it be disentangled. Galama and van Kippersluis have argued that health 
economic theory can provide valuable insights into the nature of these 
mechanisms92. Grossman’s model of health production in particular has yielded 
considerable insights into the determinants of health and the allocation of time and 
money into the production of health92. Many of its predictions are supported by 
empirical evidence, perhaps most important is the impact that education has on 
health. However the model cannot explain the inverse relationship between 
demand for medical care and health92. This is most certainly true of children with 
refractory epilepsy. In patients with refractory epilepsy, early intervention with 
curative surgery reduces the progress of epileptic encephalopathy, and both 
curative surgery and palliative surgery are associated with improved lifespan37.  
 
Health investment in epilepsy surgery clearly delivers a significant cost benefit to 
the overall healthcare system. The lived experience of caring for a unique patient 
like SL is radically different and carries more potent weight on her parents than 
the statistics that we offer. 
 
4.6 Outcome 
At the time of writing, SL’s parents have not given their consent for SL to undergo 
corpus callosotomy. They have been encouraged to seek second opinions, and have 
taken up this opportunity. Her epilepsy remains refractory and she continues to 
sustain injuries from her drop attacks. The health impact of epilepsy to SL, her 
family and the broader community remains high.  
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While VNS has not been offered, SL has however been entered on the cannabis 
trial; results are pending. While the treating team feel that corpus callosotomy will 
provide SL with the best possible outcome, they have been sensitive to her family’s 
needs. SL is a unique patient who exemplifies the individual cases that stand out 
from the evidence. As her 16th birthday draws closer, her own legal right to choose 
corpus callosotomy becomes very real. 
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5 CONCLUSIONS     
The case series presented in this thesis is one of the largest paediatric case series 
of corpus callosotomy outcomes5 and is the first in the corpus callosotomy 
literature to utilise Kaplan-Meier analysis. There were significantly fewer 
antiepileptic drugs used at last follow up and significantly fewer injuries from drop 
attacks at last follow up. It further suggests that an initial 12 month period of 
worthwhile reduction in drop attacks as well as fewer than two other types of 
seizure are prognostic of a good seizure outcome. This is new and important 
information that has not previously been reported in the literature. 
 
Case series cannot provide sufficient evidence for the efficacy and safety of an 
intervention. The highest quality evidence of course is a systematic review and 
meta-analysis of RCTs. But no such evidence exists within the corpus callosotomy 
literature. There have been a number of calls within the literature to move beyond 
the hypothesis generation of corpus callosotomy case series, towards the 
execution of an RCT and Dwivedi et al have recently presented their randomised 
results72. The multicentre trial design presented in Appendix A mirrors that of an 
already successful RCT in epilepsy surgery. However the utility of conducting such 
a trial is questionable. Is the body of evidence sufficient to support the use of 
corpus callosotomy in children with refractory epilepsy? Graham, Tisdall and Gill’s 
systematic review highlights significant methodological issues with the published 
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literature5. Rigorously designed prospective case series that use a consistent 
outcome measure may be sufficient to demonstrate a clear benefit of corpus 
callosotomy. However there remain inconsistencies between the evidence from 
case series and population studies5,34,53-67,74-76 and the results for corpus 
callosotomy in Dwivedi et al’s paper72. 
 
Yet the best evidence may not be sufficient to persuade patients and parents. The 
ethics of corpus callosotomy is set against a backdrop of fear and 
misunderstanding. While there are clear health economic advantages at the 
epidemiological level, the singular cases are what we see in clinical practice. The 
trade-off between the benefit of effective palliation and the risk of iatrogenic 
neurological harm leans towards harm in the minds of some parents. Ultimately 
the clinical ethics of corpus callosotomy in a child is dominated by the decisions of 
the patient’s family and there are no legal grounds to challenge this barrier to 
treatment. The clinical standpoint must acquiesce. 
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APPENDIX A: DESIGN OF A 
MULTICENTRE RANDOMISED 
TRIAL 
The results of the case series presented in this thesis further strengthen the 
hypothesis that corpus callosotomy is an effective palliative treatment and is well 
tolerated in paediatric patients. The need for a randomised trial has been observed 
elsewhere in the literatureA1,A2A3, but Graham, Tisdall and Gill’s systematic review 
outlines the scope of the design for an RCT of corpus callosotomy based on the 
work of Wiebe et alA1,A3. Noting the limitations outlined in sections 1.3.2 and 3.6.5, 
Dwivedi et al has achieved this to an extentA4. 
 
The advantage of using these other designs is that they afford comparison between 
results from these trials. They however note that the challenge for studying corpus 
callosotomy is the infrequency of the procedure. For instance, over the 20 year 
period covered in Chapter 2, 73 patients underwent corpus callosotomy at GOSH 
and CHW but only 55 met inclusion criteria. 
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In Harvey et al’s 2004 survey of epilepsy surgery, corpus callosotomy accounted 
for 18/543 (3.1%) of all epilepsy surgery in that yearA5. This is fairly consistent 
with published case series, Téllez-Zenteno et al’s systematic review of epilepsy 
surgeryA6. Harvey et al included a total of 7343 patients and corpus callosotomy 
accounted for 99 (1.3%)A5. Corpus callosotomy is more commonly performed in 
children than adults owing to the poorer outcomes in adults combined with the 
preference for early intervention in all epilepsy surgery. While Harvey et al did not 
report on the proportion of paediatric patients undergoing corpus callosotomy 
specifically, they did find that patients under 18 accounted for 77% of all palliative 
surgery, which included both VNS and corpus callosotomyA5. However VNS 
accounted for approxiamately 6 times as many operations in 2004 when compared 
with corpus callosotomyA5, so the exact proportion of paediatric corpus 
callosotomy patients is not clear.  
 
This appendix details the design of an RCT of corpus callosotomy. The aim will be 
to investigate whether corpus callosotomy is a safe and effective treatment of 
medically refractory generalised seizures that is characterised by injurious drop 
attacks. It would randomise patients to either corpus callosotomy plus optimised 
medical therapy or 12 months of delayed corpus callosotomy plus optimised 
medical therapy. The primary outcome would be no or rare disabling drop attacks. 
Secondary outcomes would include outcomes for other seizure types, QOL, 
disability and death. Epileptologists and neuropsychiatrists would be blinded to 
the treatment arm and assess the efficacy of optimal medical therapy and patient 
outcomes. The results of such a trial is beyond the scope of this thesis, but there is 
momentum gaining in the literature for the serious consideration of conducting 
such a trial. 
 
A.1 Main Objectives 
As discussed, the body of evidence for the safety and efficacy of corpus callosotomy 
can at best be used to propose the following null hypothesis: 
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H0: there is no significant difference in treatment outcome between patients with 
corpus callosotomy compared with patients with delayed surgical treatment. 
 
The primary objective of the trial will be to compare clinically significant 
reductions in drop attacks following randomisation. This differs slightly from 
resective surgery, as corpus callosotomy is a palliative procedure rather than a 
curative procedure. Even still, seizure freedom rates will still be reported. 
 
The secondary objectives of the trial will be to: 
1. Determine the frequency and severity of other seizures following 
randomisation; 
2. Determine patient quality of life (QOL) following randomisation; 
3. Determine patient disability following randomisation; and  
4. Determine patient mortality following randomisation. 
 
A.2 Methods and Design 
A.2.1 Design 
The trial will be a randomised, controlled trial of patients undergoing corpus 
callosotomy at various international centres. Where possible, its design will be 
similar to Wiebe et alA3 in order to facilitate robust meta-analysis. 
 
The trial will consist of two primary groups: 
1. Control group: patients assigned to 12 months ongoing optimal medical 
management followed by corpus callosotomy 
2. Anterior corpus callosotomy group: patients assigned to anterior corpus 
callosotomy combined with optimal medical management 
3. Total corpus callosotomy group: patients assigned to total corpus 
callosotomy combined with optimal medical management 
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Patients will be randomly assigned to either the control group or the treatment 
groups before inpatient clinicians will be contacted; patients will be assigned to the 
anterior corpus callosotomy group or the total corpus callosotomy group 
depending on their clinical picture. The study groups will be further stratified for 
sub analysis of adult versus paediatric outcomes and partial versus total corpus 
callosotomy outcomes. Intervention and control groups will undergo optimal 
medical management and assessment by epileptologists blinded to patient 
assignment, as well as formal assessment by neuropsychiatrists blinded to patient 
assignment.While epileptologists will know that patients have been selected for 
corpus callosotomy, the blinding that will occur will be whether the patient will 
undergo delayed treatment or early treatment. 
 
Patients will be followed for 12 months in order to assess differences in outcomes 
between intervention and control groups. The evidence presented in Graham et 
al’s case series suggests that approximately 80% of patients may continue to have 
worthwhile reduction in drop attacksA7. A follow on cohort study may be used to 
investigate the long term benefits of corpus callosotomy.  
 
Ethics approval for this study will be obtained independently from the various 
centres. The trial will be registered on clinicaltrials.gov.  
 
A.2.2 Participants 
All patients referred to the individual epilepsy surgery centres will be selected for 
the trial if they satisfy the following inclusion criteria: 
1. Failure of 3 or more AED 
2. Seizure semiology involves generalised or multifocal epilepsy that includes 
drop attacks (tonic, atonic or myoclonic) 
3. No previous epilepsy surgery 
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A.2.3 Workup and Surgical Approach 
Patients will be worked up for corpus callosotomy prior to randomisation in 
accordance with the guidelines for epilepsy surgery described by Cross et alA8: 
1. EEG: interictal scalp EEG including natural sleep recordings, as well as VEEG 
for recording ictal events. These will be obtained using standard techniques 
described by the International Federation of Clinical NeurophysiologyA9. 
2. Structural Imaging: 3T MRI using a specified epilepsy protocol; CT may be 
utilised in when indicated, such as calcification. Special sequences will be 
required for infants and children under 24 months old due to immature 
myelation; serial sequences will also be used in this group in order to 
identify abnormalities. Callosal volumes will be recorded. 
3. Neuropsychiatry: age appropriate intelligence, behavioural and 
development tests. 
 
The surgical approach and technique will involve a single 5x5cm craniotomy over 
the midline and centred on the coronal suture. Depending upon the vascular 
anatomy, the callosotomy will be performed to the left of the falx cerebri. Anterior 
corpus callosotomy will include any callosal section that spares the splenium, 
whereas complete corpus callosotomy will include any callosal section that 
includes the splenium. Patients with prior anterior corpus callosotomy undergoing 
further surgery for a complete corpus callosotomy will be classed as having a 
completed corpus callosotomy. 
 
A.2.4 Study Variables 
The outcome variables will be seizure outcome, neuropsychiatric outcomes, QOL 
and complications: 
1. Seizure outcome: a good outcome will be defined as free or almost free of 
seizures.  
2. Neuropsychiatric outcomes: formal age appropriate intelligence, 
developmental and behavioural assessments will be used to assess 
neuropsychiatric outcomes. 
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3. QOL: The SF-36 will be used to report QOL outcomes.  
4. Complications: Severity of surgical and neurological complications will be 
classified using a similar system to Hader et alA10, as shown in Table A.1. 
 
Table A.1. Severity of complications. CSF = cerebrospinal fluid; DVT/PE =deep 
vein thrombosis/pulmonary embolus 
 Major Minor 
Surgical complications Hydrocephalus 
Deep infections (such as 
intracerebral and 
epidural 
abscesses) requiring 
drainage 
and/or bone flap removal 
CSF leak 
Intracranial/extracranial 
infection 
Aseptic meningitis 
DVT/PE 
Pneumonia 
Intracranial haematomas 
Metabolic disturbances 
Neurological 
complications 
All neurological 
complications that 
persisted 
beyond 3 months of 
surgery 
All transient neurological 
complications resolving 
within 3 months of 
surgery 
 
The following epidemiological data will be collected at randomisation for 
multivariable analysis: 
1. Sex;  
2. Epilepsy syndrome and seizure semiology; 
3. Comorbidities; 
4. Age at surgery; 
5. Age at epilepsy onset; 
6. Investigations: 
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a. Barkovich classification of MRI findingsA11;  
b. Callosal volumes; and 
c. EEG findings using Hanson et al’s classificationA12. 
7. Neuropsychiatric assessments; 
 
A.2.5 Data Collection 
Data collection will be conducted by epileptologists and neuropsychiatrists blinded 
to randomisation. At randomisation, and at 3 month intervals post-randomisation, 
epileptologists will document a seizure record, QOL, comorbidities and disability. 
Neuropsychiatrists will conduct formal assessment of intelligence, development 
and behaviour at randomisation and at 6 month intervals post-randomisation.  
 
A database will be used for entry of the data. Data fields will include the following: 
1. Seizures: 
a. Semiology; 
b. Frequency; and 
c. Any injuries sustained in the previous 3 months that can be directly 
attributed to drop attacks. 
2. QOL:  
a. SF-36 score 
b. SF-36 section scores (vitality, physical functioning, bodily pain, 
general health perceptions, physical role functioning, emotional role 
functioning, social role functioning, mental health) 
3. EEG:  
a. Hanson Type I Ictal: generalised slow spike-wave pattern, 
electrodermal pattern, or low amplitude, fast activity without 
evolution pattern 
b. Hanson Type II Ictal: other less generalised patterns, which included 
focal features or are more chaotic; patients with Type I and Type II 
patterns will be defined as Type II 
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c. Interictal background: symmetric or asymmetric, and with or 
without slow spike wave activity.  
4. Imaging: 
a. Barkovich classification of structural MRI features; 
b. Callosal volumes; 
c. Extent of callosotomy, which will be confirmed on post-operative 
MRI. 
5. Neuropsychiatric assessment: 
a. Age appropriate intelligence scales for patients aged 30 months and 
over: Wechsler Adult Intelligence Scale, Wechsler Intelligence Scale 
for Children and the Wechsler Preschool and Primary Scale of 
Intelligence, including their index scores and the Full Scale IQ and 
General Ability Index 
b. Bayley Scales of Infant and Toddler Development for patients aged 
between 1 and 42 months, including the subset scores (cognitive, 
language, and motor) as well as parental reported subsets (social-
emotional role and adaptive behaviour); may be used in patients 
with severe developmental delay unable to complete the intelligence 
assessments 
c. Age appropriate behavioural assessment, including: Autism 
Diagnostic Interview, Autism Diagnostic Observation Schedule, and 
the Vanderbilt Assessment Scale (teacher and parent scales), Child 
Behaviour Checklist. 
 
A.2.6 Statistical Analysis 
Data will be analysed using the intention to treat principle. Significance will be 
defined as p < 0.05. Freedom from drop attacks and from other seizures will be 
determined using Kaplan-Meier event-free survival analysis curves using right-
censoring, with differences between groups assessed using log-rank tests. Cox 
proportional hazards regression used to control for differences in demographics 
and clinical characteristics. Categorical data will be compared using Fisher’s exact 
test and interval data will be compared using Mann-Whitney’s U test. The following 
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clinical features will be modelled for the primary outcome using multivariable 
logistic regression analysis: age at onset; age at surgery; type of drop attack (tonic 
vs atonic); pre-surgical ictal EEG type; size of corpus callosum; extent of 
callosotomy (anterior vs complete); diagnosis of Lennox-Gastault Syndrome (LGS), 
West Syndrome or Ohtahara Syndrome; moderate-severe developmental delay; 
and abnormal MRI features.  
 
A.2.7 Study Size 
The sample size has been calculated for a Kaplan-Meier survival analysis of the 
primary objective; the power of the secondary objectives and sub-analyses will be 
calculated in a post hoc analysis. A two-tailed model with a 0.05 probability of 
Type I error and a power of 0.8 was used.  
 
Tellez-Zenteno et al found that 35% of adult and paediatric patients were free of 
disabling drop attacksA6. In the paediatric literature, Graham et al found that 58.6% 
of anterior corpus callosotomy patients and 88.2% of total corpus callosotomy 
patients were free or almost free of drop attacksA1. Rolston et al used a 50% 
reduction in drop attacks as their cut off in adult and paediatric patientsA13, which 
is equivalent to Engel class I or II. Using this criteria, 85.6% of corpus callosotomy 
patients had at least a 50% reduction in drop attacks. Finally, up to 24% of pts with 
refractory epilepsy have been reported to achieve seizure remission for more than 
12 monthsA14, but this may be an over-estimate in this difficult to treat population. 
 
The values that were used in the sample size calculation are shown in table A.2 
below. These require a total sample of 61 patients in the control and anterior 
corpus callosotomy groups, and 45 patients in the total corpus callosotomy group. 
Assuming a retention rate of 0.8 (as in Wiebe et al’s RCTA3), the trial will require 
recruitment of 210 patients for randomisation.  
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Table A.2. Values used to calculate sample size to achieve 80% power with <5% 
Type I error. 
Group Estimated 
effectiveness 
Control 0.24 
Anterior corpus 
callosotomy 
0.50 
Total corpus 
callosotomy 
0.80 
 
A.3 Discussion 
There is a precedence to RCTs in epilepsy surgery that have demonstrated clear 
benefits of resective surgery to prolonged medical therapyA3,A4, but the results for 
corpus callosotomy in Dwivedi et al’s paper are inconsistent with the paediatric 
literatureA1. This will be the first RCT that will assess the safety and efficacy of 
corpus callosotomy and, if successfully implemented, could set the conditions for 
the design and conduct of other epilepsy surgery trials. The infrequency of the 
procedure clearly necessitates a multicentre trial, which complicates the design 
and feasibility of this trial. Should a trial seek to compare total corpus callosotomy 
to optimal medical management alone, a fewer number of patients will be required 
for randomisation in a 1:1 distribution, which may be a more feasible approach.  
 
The main strength of this trial is its blinded and randomised design. As Wiebe et al 
found in their pilot studies, neither patients nor clinicians accept randomisation 
after the patients have been worked up. Their novel approach to blinding and 
randomisation is a key factor in ensuring the validity of the design. They also found 
that only 5% of patients randomly assigned in this manner were found to be 
unsuitable for surgery following workup. A further strength of the design of this 
present trial is the fact that it modifies a previously successful design, which will 
support meta-analyses in the future. It is possible that the trial can support the 
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identification of prognostic factors that have eluded case series. This would 
support an enhanced evidence base for patient selection. 
 
This trial will be limited in a number of ways. First, patients will not be blinded but 
this is ameliorated by using Wiebe et al’s strategy of randomisation before 
contacting inpatient clinicians and using a strategy that delays treatment in the 
control group. Second, this study is not designed to test the hypothesis that 
sustained freedom drop attacks diminishes over time, as observed in Chapter 3 
and found by Telez-Zenteno et alA6. However the cohort could be followed for long 
term follow up of outcomes. Third, the design does not include VNS in the 
randomisation, which is an important minimally invasive alternative to corpus 
callosotomy.  
 
A.4 Conclusion 
The hypothesis that corpus callosotomy is a safe and effective procedure has been 
well established. The RCT described in this study protocol will be the first trial to 
assess this hypothesis. A multicentre trial will be required in order to recruit a 
sufficient number of patients, which will complicate the design and feasibility of 
this trial. A follow-on cohort study could be used to test the important hypothesis 
that freedom drop attacks following corpus callosotomy diminishes over time. 
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APPENDIX B: SEIZURE 
OUTCOME AFTER CORPUS 
CALLOSOTOMY IN A LARGE 
PAEDIATRIC SERIES 
The main publication arising from this thesis is included in this appendix. The 
reference is: 
Graham D, Gill D, Dale RC, Tisdall MM for theCorpus Callosotomy Outcomes Study 
Group. Seizure outcome after corpus callosotomy in a large pediatric series. 
Developmental Medicine and Child Neurology; doi: 10.1111/dmcn.13592  
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ABBREVIATIONS
AED Antiepileptic drug
AIM To describe 20 years of experience with corpus callosotomy at Great Ormond Street
Hospital for Children, London and the Children’s Hospital at Westmead, Sydney.
METHOD Records of patients who underwent corpus callosotomy between January 1995 and
December 2015 were reviewed. Complications of surgery and changes in seizure type and
frequency, injuries, and use of antiepileptic drugs were recorded. Drop attacks were analysed
using Kaplan–Meier event-free survival curves. Multivariable regression analysis was used to
assess the effect of clinical characteristics on outcome at last follow-up.
RESULTS Inclusion criteria were met for 55 patients younger than 18 years of age. Median
follow-up length was 36 months. At the last follow-up, 26 out of 55 patients (47%) had rare or
no drop attacks. In those without a good outcome at final follow-up, 26 out of 29 (90%) had
drop attacks return within 12 months of surgery. There were no preoperative predictors of
developing drop attacks postoperatively. The median number of antiepileptic drugs
significantly reduced from three to two. Transient neurological complications were
experienced by 11 out of 55 patients (20%) and 6 out of 55 patients had surgical
complications (11%).
INTERPRETATION Corpus callosotomy is a well-tolerated procedure that is effective at reducing
the severity of drop attacks in paediatric patients. Drop attacks that do return are likely to do so
within 12 months and the number of antiepileptic drugs can be significantly reduced.
Corpus callosotomy is a palliative treatment for patients
with either generalized or multifocal refractory epilepsy
characterized by injurious drop attacks. There are no uni-
versally accepted indications for corpus callosotomy, and
patient selection is centre- and surgeon-dependent. In a
systematic review of corpus callosotomy, paediatric patients
appeared to benefit from corpus callosotomy more fre-
quently than adults, with 88% of paediatric patients
achieving rare or no drop attacks after a compete calloso-
tomy procedure.1 Tellez-Zenteno et al. found that in stud-
ies without prolonged follow-up,2 at least 65% of patients
were likely to be either free or almost free of drop attacks
but that sustained freedom from drop attacks diminished
significantly beyond 5 years. More recently, the population
study of long-term outcomes by Stigsdotter-Broman et al.
found that sustained benefit is possible up to 10 years.3
Surgical and neurological complications do occur, but
there are typically no enduring complications in chil-
dren.1,4 Notably, disconnection syndrome, which presents
with a combination of alien limb, apraxia, tactile and/or
visual anomia, agraphia, neglect, and dyslexia, has been
reported in 13% of children undergoing complete corpus
callosotomy, which is higher than that reported in adults.1
However, unlike adults, disconnection syndrome in chil-
dren appears to always resolve within 3 months. Earlier
intervention is generally preferred in epilepsy surgery,5 and
children who undergo successful epilepsy surgery have sig-
nificantly prolonged life expectancy compared with chil-
dren managed medically.6
This paper presents a retrospective case series of out-
comes and complications of 20 years of corpus callosotomy
experience at Great Ormond Street Hospital in London
and the Children’s Hospital at Westmead in Sydney.
METHOD
For this type of study formal consent is not required.
Ethics approval for this study was granted by the Sydney
Children’s Hospital Network Human Research Ethics
© 2017 Mac Keith Press DOI: 10.1111/dmcn.13592 1
Committee (HREC Reference LNR/14/SCHN/178) and
the Great Ormond Street Hospital Clinical Audit Depart-
ment (Registration Number 1974).
Patient selection
Between January 1995 and December 2015, 76 patients
underwent corpus callosotomy at Great Ormond Street
Hospital and the Children’s Hospital at Westmead.
Patients were excluded if they (1) were 18 years or older at
the time of surgery (n=2); (2) were last seen in the immedi-
ate postoperative follow-up clinic (lost to follow-up; n=18);
or (3) underwent additional resection at the time of surgery
(n=1).
Fifty-five patients met the inclusion criteria, five of
whom subsequently underwent secondary completion of
corpus callosotomy.
Surgical work-up and approach
All patients underwent full preoperative evaluation accord-
ing to the International League Against Epilepsy recom-
mendations for referral and evaluation.7 This involved
evaluation by a multidisciplinary team involving neurolo-
gists and neurosurgeons and agreement upon case selection
before proceeding to surgery. Patients offered callosotomy
were deemed to be unlikely to benefit from resective sur-
gery but considered likely to benefit from disconnective
surgery. The decision for partial or complete corpus cal-
losotomy was based on neuropsychological assessment;
patients with poor cognitive function, especially verbal
function, were selected for complete corpus callosotomy.
Completion of corpus callosotomy was based on postoper-
ative seizure control.
Surgery was performed by specialist neurosurgeons WH
and MMT at Great Ormond Street Hospital and MD at
the Children’s Hospital at Westmead. A standard tech-
nique was used in both centres, which reduces the possibil-
ity of variability, although variability cannot be excluded. A
single craniotomy was performed over the midline and
centred on the coronal suture. Depending upon the vascu-
lar anatomy, the callosotomy was performed to the left of
the falx cerebri. The dissection was taken to the planned
posterior extent of the corpus callosotomy and then anteri-
orly to the anterior cerebral arteries. Anterior corpus cal-
losotomy included any callosal section that spared the
splenium and all or part of the isthmus. Complete corpus
callosotomy included any callosal section that divide the
splenium. There are no anatomical landmarks so neuronav-
igation offers the best intraoperative decision tool. The
loss of accuracy as the division advances is small owing to
the fact that the procedure is midline.
Follow-up
All patients were followed up within 6 weeks of surgery.
Owing to the severity and complexity of refractory general-
ized epilepsy, most patients were followed-up regularly
with formal review. Further investigations were conducted
when a patient’s epilepsy was worsening or new seizure
types were emerging. The patient was considered lost to
follow-up if they had less than 3 months of follow-up. The
authors attempted to contact all patients who were lost to
follow-up, but contact could only be made with two
patients and they were included in the case series. A total
of 18 patients were lost to follow-up.
Data
Data were sourced from clinical records to ascertain the
clinical progression of seizure semiology. Seizure semiol-
ogy was recorded using the 1989 International League
Against Epilepsy classification of seizures.8 Drop attacks
were classified as tonic, atonic, or myoclonic.8 The Barko-
vich classification system was used to classify abnormal
magnetic resonance imaging (MRI) findings.9 The extent
of callosotomy was confirmed on follow-up MRI for 31
patients. Confirming the extent of callosotomy on postop-
erative imaging was not standard practice for patients dur-
ing the period of this data collection but would be valuable
in a prospective study.
Outcomes
The primary outcome for this study was frequency of drop
attacks; a good outcome was defined as free of drop
attacks or rare drop attacks. While there is some contro-
versy over the use of the Engel classification system in dis-
connective surgery, it is clinically relevant and commonly
used in clinical practice for reporting epilepsy surgery out-
comes after corpus callosotomy.1 Therefore, the Engel
classification system was used as the basis for the definition
of good outcome in this paper;10 the phrase ‘Engel Class
I–II’ has not been used in order to avoid confusion as this
could imply ‘completely or almost seizure free’. Severity of
surgical and neurological complications were classified
according to the same classification system as Hader
et al.11 Neurological complications were assessed by the
treating neurologist. The following secondary outcomes
were also included: (1) other seizure outcomes at last follow-up
– frequency of generalized seizures, partial seizures, and
spasms at last follow-up, including new-onset seizures (a
good outcome for other seizures is defined as rare or no
seizures of this type after surgery, aligning with Engel
class I–II); (2) injury outcomes at last follow-up – number of
patients who regularly sustained injuries as a result of their
drop attacks at the time of surgery compared with number
at last follow-up; (3) changes in the number of antiepileptic
drugs (AEDs) at last follow-up – the number of AEDs at the
time of surgery compared with the number of AEDs at
last follow-up.
What this paper adds
• Corpus callosotomy is an effective palliative treatment and well tolerated in
children.
• Good outcomes for the first 12 months after surgery were likely to continue.
• The number of antiepileptic drugs can be significantly reduced after corpus
callosotomy.
• Patients with fewer than three types of seizure had better outcomes.
• There were fewer injuries from drop attacks after surgery.
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Neuropsychological changes at last follow-up were not
included as postoperative formal assessment was not regu-
larly conducted and this paper is a reflection of actual
practice.
Statistical analysis
All statistical analysis were conducted using SAS version
9.4. Categorical data were compared using Fisher’s exact
test and interval data were compared using the Mann–
Whitney U test. The duration of good drop attack out-
come was analysed using Kaplan–Meier event-free survival
curves using right-censoring of data and the log-rank test;
right-censor date was 31st December 2015. The following
clinical features were modelled using the log-rank test for
statistical significance, as well as multivariable logistic
regression analysis: age at onset; age at surgery; tonic drop
attacks; extent of callosotomy (anterior vs complete); diag-
nosis of Lennox–Gastaut syndrome, West syndrome, or
Ohtahara syndrome; moderate-to-severe developmental
delay; and abnormal MRI features. Backward selection was
used for the multivariable logistic regression model; Wald
v2 statistic was used to test for significance and Harrell’s C
statistic was used for goodness of fit. Initial seizure-free
period of 12 months, 18 months, and 24 months postoper-
atively was also analysed using a landmark analysis and the
log-rank test for statistical significance. The landmark anal-
ysis assessed the effect of an initial period of 12 months of
good outcome of drop attacks (the ‘cut-off period’). Two
groups were considered with this approach: (1) all patients;
and (2) patients who were right-censored beyond the cut-
off period or who had drop attacks return after that period.
Kaplan–Meier survival curves of these two groups of
patients were compared using log-rank statistics. All p-
values were two-tailed and significance was defined as
p<0.05.
RESULTS
Patient demographics
Preoperative demographic data are shown in Table I.
Median age at surgery was significantly greater at the
Children’s Hospital at Westmead (147.5mo vs 111mo;
p=0.02), and there were significantly more patients with
myoclonic–atonic drop attacks (6 vs 0; p<0.01), atonic sei-
zures (3 vs 0; p<0.05), and myoclonic seizures (12 vs 6;
p<0.01) at the Children’s Hospital at Westmead. A total
of 11 out of 55 patients underwent anterior corpus
callosotomy, 43 out of 55 patients underwent complete
corpus callosotomy.
In total, before surgery 4 out of 55 patients had only
drop attacks, 9 out of 55 patients had drop attacks plus
one other type of seizure, 22 out of 55 patients had drop
attacks plus two other types of seizure, and 20 out of 55
patients had drop attacks plus at least three other types of
seizure. All patients had some degree of developmental
delay (n=55); in 49 patients this was moderate-to-severe.
Structural brain abnormality was the most common known
epilepsy aetiology (n=15). Other aetiologies included
genetic (n=8), infectious (n=3), and immune mediated
(n=1). Comorbidities other than developmental delay
included cerebral palsy (n=10), autism spectrum disorder
(n=10), attention-deficit–hyperactivity disorder (ADHD)
(n=8), and sensorineural hearing loss (n=2). Three patients
had two comorbidities other than developmental delay
(cerebral palsy with autism spectrum disorder, cerebral
palsy with ADHD, and autism spectrum disorder with sen-
sorineural hearing loss).
Table I: Preoperative demographics
Demographic GOSH CHW All p
N of patients 33 22 55 –
M:F 25:8 11:11 36:19 0.08
Extent of callosotomy
Anterior 8/33 3/22 11/55 0.29
Complete 24/33 19/22 43/55 0.24
Completed 3/8 2/3 5/11 1.00
Abandoned 1/33 0/22 1/55 1.00
Lennox–Gastaut
syndrome
15/33 12/22 27/55 0.59
West syndrome 4/33 0/22 4/55 0.14
Ohtahara
syndrome
2/33 0/22 2/55 0.51
Known aetiology 20/33 11/22 31/55 0.57
Moderate-to-
severe
developmental
delay
28/33 21/22 49/55 1.00
Other
comorbiditiesa
19/33 10/22 29/55 0.41
Median (IQR) age (mo)
Epilepsy onset 10 (31) 24 (25) 12.5 (30) 0.81
Surgery 111 (90) 147.5 (52.25) 125 (81.5) 0.02
Investigations
Abnormal MRI 18/33 12/22 30/55 0.19
Chromosome
abnormality
1/2 0/2 1/4 1.00
Microdeletion 4/11 3/6 7/17 1.00
Seizure semiology at the time of surgery
Drop attacks
Tonic 9/33 7/22 16/55 1.00
Atonic 16/33 5/22 21/55 0.15
Myoclonic 1/33 3/22 4/55 0.63
Myoclonic–
atonic
0/33 6/22 6/55 <0.01
Not stated 6/33 1/22 7/55 0.23
Other generalized seizures
Tonic–clonic 13/33 9/22 22/55 1.00
Absence 17/33 8/22 25/55 0.57
Tonic 12/33 10/22 22/55 0.57
Atonic 0/33 3/22 3/55 0.05
Myoclonic 6/33 12/22 18/55 <0.01
None 5/33 1/22 6/55 0.39
Focal seizures 6/33 6/22 12/55 0.33
Spasms 9/33 3/22 12/55 0.50
Therapies at time of surgery
Median (IQR)
AED
3 (1) 3 (2) 3 (1) 0.37
Active VNS 2 0 2 0.52
Median (IQR)
follow-up (mo)
33 (34) 42 (30.25) 36 (34) 0.52
Data are n unless otherwise indicated. aExcluding developmental
delay. GOSH, Great Ormond Street Hospital; CHW, Children’s
Hospital at Westmead; M, male; F, female; IQR, interquartile range;
MRI, magnetic resonance imaging; AED, antiepileptic drug; VNS,
vagus nerve stimulator.
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Complications
Neurological complications occurred in 11 out of 55
(20%) surgeries and all resolved within 6 weeks. These
included hemiparesis (n=7), disconnection syndrome (n=2),
gait ataxia (n=1), and aphasia (n=1). Disconnection syn-
drome occurred in one patient with anterior corpus cal-
losotomy and one patient with complete corpus
callosotomy. Minor surgical complications occurred in 6
out of 55 (11%) surgeries and included intracranial haema-
toma that did not require surgical evacuation (n=2), pyrexia
(n=2), and intracranial infection (n=1). The only major
complication was hydrocephalus (n=1) and there were no
deaths. There was no significant difference in complica-
tions between anterior corpus callosotomy and complete
corpus callosotomy (minor neurological 1/11 vs 6/43
[p=0.67]; minor surgical 1/11 vs 4/43 [p=1.00]; major surgi-
cal 0/11 vs 1/43 [p=1.00]).
Primary outcome
Median follow-up postoperatively was 36 months (in-
terquartile range 34mo, range 7–131mo). Figure 1 shows
the frequency of drop attacks preoperatively and at last fol-
low-up.
Overall, 26 out of 55 (47%) patients achieved a good
outcome for drop attacks at last follow-up. Of the children
with a poor postoperative drop attack outcome, 26 out of
29 (90%) of these patients had a return of drop attacks
within 12 months of surgery. The Kaplan–Meier survival
curve of good outcome for drop attacks is shown in Fig-
ure 2a. This shows the number of months post-callosot-
omy that patients had a worthwhile reduction in drop
attacks. Log-rank statistics for clinical features correlated
with good outcome are shown in Table II.
A landmark analysis is shown in Figure 2b. The results
for cut-off periods of 12 months, 18 months, and
24 months are shown in Table III, including the propor-
tion of patients who continue to have good outcome for
drop attacks after the cut-off period. The results are not
significant when the cut-off period is 6 months (p=0.07).
Secondary outcomes
Patients with drop attacks plus one other seizure type
before surgery were significantly more likely to achieve a
good outcome for other seizures compared with patients
with two other seizure types or three or more other seizure
types (100% vs 23% [p<0.01]; 100% vs 10% [p<0.01]).
The number of other seizure types were not associated
with any statistically significant differences in outcome for
drop attacks. The overall outcome and the frequency of
other seizure types is shown in Figure 3.
There was a significant reduction in the number of patients
who were regularly sustaining injuries caused by their drop
attacks (77% preopertively vs 21% at last follow-up; p<0.01).
Among patients who continued to have drop attacks at the
time of last follow-up, there was also a significant reduction
in the number of patients sustaining injuries (73% preopera-
tively vs 42% at last follow-up; p=0.05) (Fig. 1).
A total of 7 out of 55 patients had developed new-onset
partial seizures at last follow-up and 3 out of 55 patients
had developed new-onset generalized seizures at last fol-
low-up. There were no significant differences in new-onset
seizures between patients with good outcome for drop
attacks and patients with poor outcome for drop attacks
(new partial seizures 5/26 patients vs 2/29 patients
[p=0.24]; new generalized seizures 2/26 patients vs 1/29
patients [p=0.60]).
The median number of AEDs used before surgery was
three (interquartile range 1), whereas at last follow-up the
median number of AEDs was two (interquartile range 1).
A two-tailed paired Student’s t-test showed that there were
significantly fewer AEDs used at last follow up compared
with preoperatively (p<0.01).
Multivariable regression analysis
Multivariable logistic regression analysis of good outcome
for drop attacks using backward selection had a Harrell’s
C-statistic of 0.66 and a maximum rescaled R2 value of
0.14. None of the clinical features described in the method
reached statistical significance.
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Figure 1: Frequency of drop attacks and proportion of patients who suffer injuries from drop attacks pre-surgery and at last follow-up. [Colour figure
can be viewed at wileyonlinelibrary.com]
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DISCUSSION
Despite the heterogeneity of patients in this case series on
paediatric outcomes of corpus callosotomy, there were very
few differences between the two centres. All patients had
some degree of developmental delay, with the majority
having moderate-to-severe developmental delay and almost
half of the patients having at least one other comorbidity.
Lennox–Gastaut syndrome, West syndrome, and Ohtahara
syndrome were the most common syndromes. All patients
had been investigated with MRI as part of their work-up;
55% had an abnormality. Genetic causes were found in
15% of patients.
In a systematic review of corpus callosotomy in paedi-
atric patients, Graham et al. reported that 88% of total
corpus callosotomy patients achieved a worthwhile reduc-
tion in drop attacks compared with 59% of patients with
partial corpus callosotomy,1 which is higher than the out-
comes in the present study. Our landmark analysis showed
that there was a significant effect of at least 12 months of
worthwhile benefit of corpus callosotomy on drop attacks
(p<0.05). Indeed, 81% of patients who did have a return of
drop attacks did so within 12 months of follow-up, similar
to the case series by McInerney et al.12 However, patients
who continued to have drop attacks after surgery were less
likely to sustain injuries, which supports the use of corpus
callosotomy for palliation. Other long-term studies have
shown sustained benefit.3 This may suggest that a good
drop attack outcome at 12 months could be a clinically
valuable postoperative marker for sustained good drop
attack outcome. Interest is also turning towards selective
posterior corpus callosotomy, with the recent study by
Paglioli et al. finding 30 out of 36 patients were either free
or almost free of drop attacks at last follow-up.13 However,
this must be contrasted with the older study by Pinard
et al. in which the patients who underwent posterior cor-
pus had poor outcomes.14
All other clinical factors were not associated with a sig-
nificant effect on the outcome of drop attacks. The extent
of callosotomy is the factor that has been reported as that
most commonly associated with seizure outcome;1 how-
ever, our series found no significant effect of extent. This
may be owing to a combination of factors, such as the
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Figure 2: Survival estimates for good drop attack outcome. (a) Kaplan–Meier survival curve; (b) landmark analysis comparing patients who have good
drop attack outcome for an initial 12 months postoperatively compared with all patients. CCx, corpus callosotomy. [Colour figure can be viewed at
wileyonlinelibrary.com]
Table II: Log-rank statistics for clinical features as predictors of good
drop attack outcome
Clinical feature Log-rank p
Age at epilepsy onset <median age at onset 0.65
Age at surgery <median age at surgery 0.49
Tonic drop attack 0.21
Total corpus callosotomy 0.16
LGS spectrum 0.82
Moderate-to-severe developmental delay 0.86
Abnormal MRI 0.41
LGS, Lennox–Gastaut syndrome; MRI, magnetic resonance
imaging.
Table III: Landmark analysis for patients who have good drop attack
outcome for an initial period of 12 months, 18 months, or 24 months
compared with all patients
Cut-off
period
(mo)
N of
patients
with
follow-up
longer
than the
cut-off
N of
patients
with good
outcome
during the
cut-off period
Proportion
of patients
who continue
to have
good outcome
after the cut-off Log-rank p
12 52 26 0.81 <0.01
18 50 23 0.83 <0.01
24 49 19 0.95 <0.001
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relatively smaller number of patients with partial corpus
callosotomy in our case series and the fact that determina-
tion of the extent of callosotomy was not solely based on
postoperative imaging. Furthermore, these factors could
explain the wide confidence interval for odds of good out-
come being attributed to complete or subtotal corpus cal-
losotomy in our logistic regression analysis.
Corpus callosotomy was well tolerated regardless of the
extent of callosotomy. The complication rate in our series
was comparable to the paediatric literature.1 The prospec-
tive, population-based study by Bjellvi et al. perhaps pro-
vides the best evidence of complications after epilepsy
surgery and they used a similar classification system to
ours.15 They observed that the complication rate may be
under-reported in the literature as most studies are retro-
spectively designed. Although their study was limited to a
single country and only 24 corpus callosotomies were per-
formed on paediatric patients, they found that no patients
developed a minor complication and only one patient
developed a major (unspecified) complication.
Notably, the findings in our series for disconnection
syndrome differ from the literature. While the literature
suggests that approximately 12% of paediatric patients will
experience a transient disconnection syndrome, which is
significantly more likely in complete corpus callosotomy
(p<0.001),1 our series found there was no significant
likelihood of disconnection syndrome occurring nor was
there any significant difference in outcome for complete
versus anterior corpus callosotomy (p=0.37). This may be
owing, in part, to the fact that the extent of callosal section
in our series was largely based on the intraoperative sur-
geon’s (MMT, WH and MD) report.
Transient hemiparesis is a common complication in the
literature,1 and it was the most common complication in
our series (13%). There are two hypotheses to account for
the reversible hemiparesis. The usual assumption is that it
is associated with the retraction of the contralateral leg
motor area. This hypothesis could be confirmed with diffu-
sion-weighted imaging. However, it is also possible that
the hemiparesis is caused by the interruption of venous
drainage relating to the division of central cortical veins in
order to gain access to the interhemispheric fissure. This
alternate hypothesis could be confirmed with a study that
investigates any relationship between the number of veins
divided during surgery and any postoperative deficits.
There were significantly fewer AEDs used at last follow-
up compared with preoperatively (p<0.05), which is differ-
ent to the paediatric literature.1 This may reflect a strategy
for optimizing AED usage in order to reduce the number
of side effects. This could explain the relatively poorer out-
come for drop attacks compared with the literature. How-
ever, the complex interplay between corpus callosotomy,
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optimal medical management, and AED side effects is
beyond the scope of this paper and has not been explored
in the literature.
The benefit on other seizures was generally poor and
was not correlated with drop attack outcome. It is not
entirely clear whether the emergence of new seizure types
is a reflection of the impact of the surgery or the evolution
of the epilepsy. However, patients who had only one other
seizure type benefited from corpus callosotomy for both
drop attacks and the other seizure type. This may be
indicative of the severity of seizure semiology before sur-
gery, which, if appropriately defined, could prove to be
another clinically relevant prognostic marker.
To date, all studies of corpus callosotomy outcomes in
paediatric patients have focused on outcome at last follow-
up.1 This is the first study of corpus callosotomy to inves-
tigate the temporal aspect of outcome for drop attacks.
This is also one of the largest studies of corpus calloso-
tomy in the paediatric population,1,16,17 which highlights
the value of combining outcomes between centres.
There are several limitations to this study. The key limi-
tation is the retrospective case series design. This may lead
to the inaccurate reporting of some data, such as the full
seizure semiology, any injuries from drop attacks, and the
neuropsychological impact. While this introduces bias into
the results, the study is useful as it does identify new infor-
mation about the durability of seizure outcomes within the
hypothesis that corpus callosotomy is a safe and effective
palliative treatment for paediatric patients with generalized
seizures characterized by drop attacks. Moreover, this
paper is a reflection of actual practice, and prospective data
collection was not possible. Postoperative neuropsychologi-
cal assessments, postoperative electroencephalography
studies, and postoperative MRI were not completed for all
patients. Finally, there are potential centre differences in
patient selection, work-up, and surgical approach. While
both centres use International League Against Epilepsy
recommendations for referral and evaluation,7 there may
be differences before 2006.
As discussed elsewhere in the literature,1,18 there is a
clear need for a randomized control trial of corpus calloso-
tomy outcomes compared with optimal medical manage-
ment. The design of such a trial was outlined by Graham
et al. in their systematic review based on the landmark ran-
domized controlled trial of Wiebe et al. of temporal lobec-
tomy.1,19 The prognostic benefit of an initial 12-month
period of worthwhile benefit on drop attacks identified in
this paper could aid the design of such a trial. A
prospective design would allow for imaging to confirm the
extent of the callosotomy, and could include recording the
number of emergency and intensive care admissions for
injuries and other complications of epilepsy. However,
enrolling a sufficient number of patients would be chal-
lenging given the relative infrequency of the procedure.
Moreover, there may be limited enrolment given the chal-
lenges faced by parents in consenting to corpus calloso-
tomy after extended periods of optimal medical
management. Imaging studies comparing semiology of
drop attacks, as well as other seizures pre- and post-callo-
sotomy may provide some insight into the seizure out-
comes reported here and elsewhere. They have the
potential to provide insight into the long-term tracto-
graphic changes post-callosotomy, as well as to why
reported outcomes in children are generally better than
those of adults.
CONCLUSION
This is one of the largest paediatric case series of corpus
callosotomy outcomes,1 and is the first in the corpus cal-
losotomy literature to utilize Kaplan–Meier analysis. As
observed previously in the literature, the results of this pre-
sent case series serve to further strengthen the hypothesis
that corpus callosotomy is an effective palliative treatment
and is well tolerated in paediatric patients. There were sig-
nificantly fewer AEDs used at last follow-up and signifi-
cantly fewer injuries from drop attacks at last follow-up. It
further suggests that fewer than two other types of seizure
preoperatively, and an initial 12-month period of worth-
while reduction in drop attacks, are prognostic of a good
seizure outcome. Owing to the limited number of cases
seen in major children’s hospitals, it is clear that a multi-
centre randomized trial is needed.
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